• SHOP
    • COMBOS
    • TESTIMONIALS
    • CART
    • INGREDIENTS
      • 2-Deoxy-D-Glucose (2DG)
      • Acacia Cyanophylla Flower
      • Acori Graminei Rhizoma
      • Aegle Marmelos Correa
      • Agaricus Blazei
      • Aged Garlic Extract
      • Aframomum Melegueta
      • Aloe Arborescens
      • Albizia
      • Alpinia Officinarum
      • Alternanthera Sessilis
      • American Ginseng
      • Amygdalin
      • Anacyclus Pyrethrum
      • Angelica Archangelica
      • Angelica Sinensis
      • Antrodia
      • Artichoke Leaf
      • Artocarpin
      • Ajuga Turkestanica
      • Ashwagandha
      • Aspalathin
      • Astragalus Complanatus
      • Avena Sativa
      • Bacopa Monnieri
      • Bavachin
      • Bee Pollen
      • Betulinic Acid
      • Boswellic Acid
      • Brevilin A
      • Campesterol
      • Casticin
      • Chrysin
      • Cinnamomum Zeylanicum
      • Citrullus Colocynthis
      • Citrus Reticulata Peel
      • Codonopsis
      • Costunolide
      • Cucurbitacin D
      • Daidzein
      • Decursin
      • Delphinidin
      • Digitalis Purprea (Digoxin)
      • Diosmin
      • Embelin
      • Gallic Acid
      • Glycitein
      • Glycyrrhizin
      • Hyperforin
      • Icariin
      • Isorhamnetin
      • Isoorientin
      • Isovitexin
      • Jaceosidin
      • Kaempferol
      • Kurarinone
      • Lemon balm
      • Licoricidin
      • Lipoic acid
      • Lupeol
      • Magnolol
      • Mulberry Leaf
      • Naringenin
      • Nobiletin
      • Oleacein
      • Oleanolic acid
      • Oridonin
      • Parthenolide
      • Phloroglucinol
      • Piceatannol
      • Pristimerin
      • Proanthocyanidins
      • Procyanidin B3
      • Pseudolaric acid b
      • Pterostilbene
      • Rutin
      • Solidago Virgaurea
      • Tangeretin
      • Taraxasterol
      • Trichostatin A
      • Wedelolactone
      • Wogonin
      • Yerba Mate
    • ABOUT
    • SCIENTIFIC STUDIES
      • ALLERGIES & CYTOKINES
      • ANTI-ACNE EFFECT OF FLAVONOIDS AND POLYPHENOLS
      • ADVANCED GLYCATION END PRODUCTS (AGES)
      • AMPK
      • ANTI-AGING EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-APOPTOTIC PATHWAYS
      • ANTI-CANCER EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-INFLAMMATORY EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-VIRAL EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • APOPTOSIS
      • AUTOPHAGY
      • BCL-2
      • BCL-W
      • BCL-XL
      • BECLIN-1 & AUTOPHAGY
      • BH3 MIMETICS
      • BIM aka BCL2L11
      • BMI-1
      • CARDIAC GLYCOSIDES
      • CENTENARIANS
      • CYP2E1
      • CYTOKINES IN PAIN, INFLAMMATION & AGING
      • DAF-16
      • EPIGENETIC MODIFIERS
      • FGF21
      • KLOTHO
      • FASTING, CALORIE RESTRICTION & EXTENDING LIFESPAN
      • FOXO3
      • FOXO4
      • HMGB1
      • HSP90 INHIBITORS
      • HYPERINSULINEMIA
      • IKK
      • IL-6/STAT3
      • INFECTOBESITY
      • INFLAMMATION & ANXIETY
      • INFLAMMATION & CANCER
      • INFLAMMATION & DEPRESSION
      • INFLAMMATION & OBESITY
      • INFLAMMAGING
      • INSULIN & AGING
      • JAK INHIBITION ALLEVIATES SASP
      • JNK ACTIVATION PREVENTS PREMATURE SENESCENCE
      • KETONE BODIES
      • KETOGENIC DIET
      • LIFESPAN EXTENSION
      • MATRIX METALLOPROTEINASES (MMPs)
      • MCL-1
      • MDM2 INHIBITION AS SASP INHIBITOR
      • MSG (MONOSOSODIUM GLUTAMATE)
      • mTOR: THE RAPID AGING PATHWAY
      • NEUROINFLAMMATION
      • NMDA & ANXIETY & DEPRESSION
      • NOOTROPICS
      • NRF2: MASTER REGULATOR OF THE AGING PROCESS
      • NF-KB
      • ONCOGENE ACTIVATION INDUCED SENESCENCE
      • OXIDATIVE STRESS & AGING
      • P16INK4A
      • P38MAPK
      • P53: TUMOR SUPRESSOR
      • PPARY2
      • PREMATURE SENESCENCE
      • SASP & ADIPOSE TISSUE
      • SENESCENT CELLS, SASP & SENOLYTICS
      • SENESCENCE-BETA-GALACTOSIDASE (SA-β-gal or SABG)
      • SKIN PHOTOAGING (Preventing & Repairing)
      • SIRT1 & LONGEVITY
      • SUGAR & AGING
      • STAT3
      • TELOMERE SHORTENING & PREMATURE AGING
    • HOME
    • FAQ
    • CONTACT
    • INTERSTELLAR 88/8: EXTREME WEIGHTLOSS PROTOCOL
    • The Ultimate Dry Fasting Resource
    Wedelolactone
    February 20, 2020
    ANTI ADIPOGENIC
    July 6, 2020

    1. -drug interaction potential of 1, 5-dicaffeylquinic acid, a new herbal drug for the treatment of hepatitis B and human immunodeficiency virus
    2. … -enriched extract from Myrothamnus flabellifolia Welw. exerts antiviral activity against herpes simplex virus type 1 by inhibition of viral adsorption and penetration
    3. … -inhibitory protein 1α, and the eosinophil product major basic protein are released into upper respiratory secretions during virus -induced asthma exacerbations in …
    4. … , a main prenylated chalcone from hops, reduces liver damage and modulates oxidative reaction and apoptosis in hepatitis C virus infected Tupaia belangeri
    5. … , and therapeutic targets of antiviral agents: Focusing on the antiviral approaches and clinical perspectives of anthocyanins in the management of viral …
    6. … , polysaccharopeptide, polysaccharide, alkaloid, coumarin and trypsin inhibitors for inhibitory activity against human immunodeficiency virus reverse transcriptase and …
    7. … ) fruit extract (2 R, 4 R)-1, 2, 4-trihydroxyheptadec-16-yne inhibits dengue virus replication via upregulation of NF-κB–dependent induction of antiviral …
    8. … [3,2-d]pyrimidin-4-ones as Potent, Highly Selective, and Orally Bioavailable Inhibitors of the Human Protooncogene Proviral Insertion Site in Moloney Murine Leukemia virus …
    9. … a bacterial cholesterol dehydrogenase, a bacterial UDP‐galactose‐4‐epimerase, and open reading frames in vaccinia virus and fish lymphocystis disease virus
    10. … A virus Subtypes H1N1, H1N2 and H3N2, HDFx: A Novel Immunomodulator and Potential Fighter Against cytokine Storms in viral Flu Infections-Carica …
    11. … acid isolated from Laggera pterodonta suppressed RIG-I/NF-KB/STAT1/Type I interferon and programmed death-ligand 1/2 activation induced by influenza A virus in …
    12. … and biological evaluation of the compounds of Justicia gendarussa leaves extract as interferon gamma inducer: a study of anti Human immunodeficiency virus (HIV) …
    13. … and Functional Diversity of the 5′ Untranslated Region of Enterovirus D68: Increased Activity of the Internal Ribosome Entry Site of viral Strains during the 2010s
    14. … and identification of Naphthoquinones from Euclea natalensis with activity against Mycobacterium tubercolosis, other pathogenic bacteria and Herpes simplex virus
    15. … antiviral action of a polyphenolic complex isolated from the medicinal plant Geranium sanguineum L. VIII. Inhibitory effect on the reproduction of herpes simplex virus …
    16. … APPROACH ON UNDERSTANDING STRUCTURAL INTERACTIONS OF ENVELOPE PROTEIN OF DENGUE virus BOUND WITH SQUALENE, A …
    17. … azido-reductase in human liver microsomes: activation by ethacrynic acid, dipyridamole, and indomethacin and inhibition by human immunodeficiency virus protease …
    18. … B virus e antigen production is dependent upon covalently closed circular (ccc) DNA in HepAD38 cell cultures and may serve as a cccDNA surrogate in antiviral …
    19. … Characterization of a Polysaccharide Fraction from Platycladus orientalis (L.) Franco and Its Macrophage immunomodulatory and Anti-Hepatitis B virus Activities
    20. … Chemical Composition of extract s from Ageratina havanensis Collected in Two Different Phenological Stages by FIA-ESI-IT-MSn and UPLC/ESI-MSn: antiviral …
    21. … CYP1A1 gene by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin but not by β-naphthoflavone or 3-methylcholanthrene is altered in hepatitis C virus replicon-expressing cells
    22. … et Gilg Using Ultra-High Performance Liquid Chromatography/Hybrid Quadrupole-Orbitrap Mass Spectrometry and Preliminary Screening for Anti-Influenza virus …
    23. … FOR IDENTIFICATION OF PROMISING ANTIMICROBIALS OF herbal ORIGIN AGAINST HIGHLY VIRULENT STRAINS OF INFLUENZA virus
    24. … Fractions of Lingzhi or Reishi Medicinal Mushroom, Ganoderma lucidum (Higher Basidiomycetes) extract Inhibit Neuraminidase Activity in Newcastle Disease virus …
    25. … from Astragalus Melittin ameliorates inflammation via suppressing the activation of TLR-4/NF-κB p65 signal pathway and protects mice from CVB3-induced virus …
    26. … herb extract s ameliorate impaired growth performance and intestinal lesion of newborn piglets challenged with the virulent porcine epidemic diarrhea virus
    27. … inhibitor, improves the motor activity and dopamine content of basal ganglia in a rat model of Parkinson’s disease induced by Japanese encephalitis virus
    28. … investigations on the response capacities of Guinean traditional health practioners in the management of outbreaks of infectious diseases: The case of the Ebola virus …
    29. … marine natural organisms with antituberculosis, antimalarial, leishmaniasis, trypanosomiasis, anthelmintic, antibacterial, antifungal, antiprotozoal, and antiviral …
    30. … molecular docking and molecular dynamics to predict the binding modes of flavonoid derivatives with the neuraminidase of the 2009 H1N1 influenza A virus
    31. … novel dengue virus inhibitor, BP13944, discovered by high-throughput screening with dengue virus replicon cells selects for resistance in the viral NS2B/NS3 protease
    32. … of 3-C-Hydroxymethyl-substituted Pyrimidine and Purine Nucleosides as Potential Anti-Hepatitis Cand Purine Nucleosides as Potential Anti-Hepatitis C virus …
    33. … of Ag nanostructures using the seed extract of Pedalium murex, an ancient Indian medicinal plant : histopathological effects on the Zika virus vector Aedes aegypti and …
    34. … of chalcone-based derivatives is responsible for broad inhibition of proteasomal activity and preferential killing of human papilloma virus (HPV) positive cervical …
    35. … of Novel Hybrid Dicaffeoyltartaric/Diketo Acid and Tetrazole-Substituted l-Chicoric Acid Analogue Inhibitors of Human immunodeficiency virus Type 1 Integrase
    36. … of pomegranate rind extract (PRE) and punicalagin against Herpes simplex virus (HSV) when co-administered with zinc (II) ions, and antiviral activity of PRE …
    37. … of seven sesquiterpene lactone glucosides in Ixeris dentata by high-performance liquid chromatography coupled with tandem mass spectrometry and their antiviral …
    38. … OF SICKLY CHILDREN OF GENE POLYMORPHISM (ASP299GLY) TOLL-4 AND (SER249PRO) TOLL-6 RECEPTOR WITH ACUTE RESPIRATORY viral …
    39. … of silver nanocomposites using the aqueous extract of Rubus ellipticus leaves: toxicity and oviposition deterrent activity against Zika virus , malaria and filariasis …
    40. … of zolpidem, necopidem, alpidem, saripidem, miroprofen, zolimidine, olprinone and abafungin as anti–tumor, peptide antibiotics, antiviral and central nervous …
    41. … on Performance, GI Microbial Population, Intestinal Morphology and Serum Lipids of Broiler Chickens Challenged with Infectious Bronchitis Vaccine virus
    42. … Parameters, Molecular Docking and Quantum Computations of plant Derived Compounds Exhibiting Strong Inhibitory Potential Against NS5 from Zika virus
    43. … plant extract s for their ovicidal, larvicidal and pupicidal activity against medically important human dengue, chikungunya and zika virus vector, Aedes aegypti …
    44. … report> Studies on Inhibitors of Skins Tumor Promotion XI.: Inhibitory Effects of FLAVONOIDS from Scutellaria baicalensis on Epstein-Barr virus Activation and Their Anti …
    45. … Sarcoma and Simian Sarcoma-Associated virus : I. Analysis of viral Structural Proteins, and Preparation and Characterization of Antiserum Specific for viral …
    46. … the effective materials of flavonoids-enriched extract from Scutellaria baicalensis roots based on the metabolic activation in influenza A virus induced acute lung injury
    47. … the production of unsaturated fatty acid esters and FLAVONOIDS from date palm pollen and their effects as anti-breast-cancer and antiviral agents: An in-vitro …
    48. … UNDERSTANDING STRUCTURAL INTERACTIONS OF ENVELOPE PROTEIN OF DENGUE virus BOUND WITH SQUALENE, A PROTOTYPE ANTI-viral …
    49. … with a grape seed proanthocyanidin extract downregulates proinflammatory cytokine expression in airway epithelial cells infected with respiratory syncytial virus
    50. (+)‑pinoresinol‑O‑β‑D‑glucopyranoside from Eucommia ulmoides Oliver and its anti‑inflammatory and antiviral effects against influenza A (H1N1) virus …
    51. (−)-Arctigenin as a lead structure for inhibitors of human immunodeficiency virus type-1 integrase
    52. (−)-Epigallocatechin gallate inhibits hepatitis C virus (HCV) viral protein NS5B
    53. (−)‐Epigallocatechin‐3‐gallate is a new inhibitor of hepatitis C virus entry
    54. (171) Blueberry Leaf Inhibits Hepatitis C virus RNA Replication
    55. 1-Cinnamoyl-3, 11-dihydroxymeliacarpin delays glycoprotein transport restraining virus multiplication without cytotoxicity
    56. 1, 4-Benzodioxane Lignans: An Efficient, Asymmetric Synthesis of Flavonolignans and Study of Neolignan Cytotoxicity and antiviral Profiles
    57. 1. Multi-target QSAR of antiviral drugs
    58. 14-Deoxy-11, 12-dehydroandrographolide exerts anti-influenza A virus activity and inhibits replication of H5N1 virus by restraining nuclear export of viral …
    59. 14-Noreudesmane sesquiterpenes from leaves of Nicotiana tabacum and their antiviral activity
    60. 1839321. Infection of Avian Pox virus in Oriental Turtle-Doves
    61. 2D-and 3D-QSAR studies of flavonoids, biflavone s and chalcones: antiviral , antibacterial, antifungal, and antimycobacterial activities
    62. 3D QSAR and docking study of flavone derivatives as potent inhibitors of influenza H1N1 virus neuraminidase
    63. 3D-QSAR Study of 1, 4-Benzodiazepines as Inhibitors of Syncytial virus
    64. 6.0 PHYTOCHEMICAL ANALYSIS AND IN VITRO ANTI-AFRICAN SWINE FEVER virus ACTIVITY OF extract S AND FRACTIONS OF ANCISTROCLADUS …
    65. 62 EVALUATION OF antiviral ACTIVITY AND TOLERANCE OF A NOVEL SUSTAINED RELEASE INTERFERON-ALPHA-2B (IFN-ALPHA-2BXL) …
    66. 8-Prenylkaempferol suppresses influenza A virus -induced RANTES production in A549 cells via blocking PI3K-mediated transcriptional activation of NF-κB and IRF3
    67. 9 Nutrition and Nonalcoholic and viral Liver Diseases
    68. A “building block” approach to the new influenza A virus entry inhibitors with reduced cellular toxicities
    69. A [1, 10] Phenanthroline Derivative Inhibits Influenza virus Propagation Through Modulating Mitogen-Activated Protein Kinase Signaling Pathways
    70. A cell-based, microplate colorimetric screen identifies 7, 8-benzoflavone and green tea gallate catechins as inhibitors of the hepatitis C virus
    71. A chalcone derivative reactivates latent HIV-1 transcription through activating P-TEFb and promoting Tat-SEC interaction on viral promoter
    72. A clinical study investigating the impact of adding silymarin to combined therapy (pegylated interferon+ ribavirin) on hepatitis C virus viremia
    73. A comparison of human immunodeficiency virus type-1 protease inhibition activities by the aqueous and methanol extract s of Chinese medicinal herbs
    74. A comprehensive review of the antibacterial, antifungal and antiviral potential of essential oils and their chemical constituents against drug-resistant microbial …
    75. A computational approach of antibiotics as novel drug target for Japanese encephalitis virus NS helicase/nucleoside triphosphatase
    76. A computational model for docking of noncompetitive neuraminidase inhibitors and probing their binding interactions with neuraminidase of influenza virus H5N1
    77. A dual character of FLAVONOIDS in influenza A virus replication and spread through modulating cell-autonomous immunity by MAPK signaling pathways
    78. A facile inhibitor screening of hepatitis C virus NS3 protein using nanoparticle-based RNA
    79. A flavonoid compound library screen revealed potent antiviral activity of plant -derived FLAVONOIDS on human enterovirus A71 replication
    80. A furoviral replicase recruits host HSP70 to membranes for viral RNA replication
    81. A high throughput assay of the hepatitis C virus nonstructural protein 3 serine proteinase
    82. A high-throughput virus -induced gene silencing protocol identifies genes involved in multi-stress tolerance
    83. A merged molecular docking, ADME-T and dynamics approaches towards the genus of Arisaema as herpes simplex virus type 1 and type 2 inhibitors
    84. A model to study the inhibition of nsP2B-nsP3 protease of dengue virus with imidazole, oxazole, triazole thiadiazole, and thiazolidine based scaffolds
    85. A multi-target approach for discovery of antiviral compounds against dengue virus from green tea
    86. A network flow approach to predict protein targets and flavonoid backbones to treat respiratory syncytial virus infection
    87. A new biflavonoid with antiviral activity from the roots of Wikstroemia indica
    88. A new class of hepatitis B and D virus entry inhibitors, proanthocyanidin and its analogs, that directly act on the viral large surface proteins
    89. A New Flavonol Glycoside Gallate Ester from Acer okamotoanum and Its Inhibitory Activity against Human immunodeficiency virus -1 (HIV-1) Integrase
    90. A novel flavanone derivative inhibits dengue virus fusion and infectivity
    91. A novel synthetic reversible inhibitor of sialidase efficiently blocks secondary but not primary influenza virus infection of MDCK cells in culture
    92. A novel systems pharmacology platform to dissect action mechanisms of traditional Chinese medicines for bovine viral diarrhea disease
    93. A novel viral vector-mediated RNAi of HPV16 E6 expression in human cervical cancer cell Caski
    94. A plant extract of Ribes nigrum folium possesses anti-influenza virus activity in vitro and in vivo by preventing virus entry to host cells
    95. A plant polyphenol-rich extract restores the suppressed functions of phagocytes in influenza virus -infected mice
    96. A polyphenol rich extract from Solanum melongena L. DR2 peel exhibits antioxidant properties and anti-Herpes Simplex virus Type 1 activity in vitro
    97. A polyphenol rich plant extract , CYSTUS052, exerts anti influenza virus activity in cell culture without toxic side effects or the tendency to induce viral resistance
    98. A Polyphenolic extract from Geranium Sanguineum L. Inhibits Influenza virus Protein Expression
    99. A Potential Role of the Heparan Sulfate in the Hepatitis C virus Attachment
    100. A preliminary study of virus -inhibiting effect of volatile oil from Artemsia argyi [J]
    101. A proteomic analysis of the anti-dengue virus activity of andrographolide
    102. A Randomized Open Label Parallel Group Clinical Study to Evaluate the Efficacy and Safety of Clevira in Fever of viral Origin
    103. A review of ethnobotany, phytochemistry, antiviral and cytotoxic/anticancer potential of morus alba linn
    104. A review of selected bee products as potential anti-bacterial, anti-fungal, and anti-viral agents
    105. A Review of the antiviral Properties of Black Elder (Sambucus nigra L.) Products
    106. A review of the antiviral role of green tea catechins
    107. A review of West Nile and Usutu virus co-circulation in Europe: how much do transmission cycles overlap?
    108. A Review on Antitumor and antiviral Potential of Cranberries (Vaccinium Vitis-Idaea) Origin from Bulgaria
    109. A review on antiviral activity of the Himalayan medicinal plant s traditionally used to treat bronchitis and related symptoms
    110. A review on recent developments of indole-containing antiviral agents
    111. A review on treatment of Human immunodeficiency virus (HIV) by Naturopathy
    112. A review study on the effect of Iranian herbal medicines against in vitro replication of herpes simplex virus
    113. A search for anti-viral properties in Panamanian medicinal plant s.: The effects on HIV and its essential enzymes
    114. A simple method for isolation and detection of rubella virus in Vero cells
    115. A study on the antiviral action of a polyphenolic complex isolated from the medicinal plant Geranium sanguineum L. VIII. Inhibitory effect on the reproduction of herpes …
    116. A Study on the antiviral Effect of Dongfang Antivirus Capsule [J]
    117. A synthetic derivative of houttuynoid B prevents cell entry of Zika virus
    118. A Theoretical Model to Study the Interaction of Erythro‐Noscapines with nsP3 protease of Chikungunya virus
    119. A-type proanthocyanidin s from lychee seeds and their antioxidant and antiviral activities
    120. Abalone hemocyanin blocks the entry of herpes simplex virus 1 into cells: a potential new antiviral strategy
    121. Accelerated cancer aggressiveness by viral oncomodulation: New targets and newer natural treatments for cancer control and treatment
    122. Activation of Cellular Immunity in Herpes Simplex virus Type 1‐Infected Mice by the Oral Administration of Aqueous extract of Moringa oleifera Lam. Leaves
    123. Activation of cGAS-dependent antiviral responses by DNA intercalating agents
    124. Active Ingredients of Anti-influenza virus in Chinese Herbs [J]
    125. Active ingredients of anti/influenza A virus in natural medicines
    126. Activity investigation of pinostrobin towards herpes simplex virus -1 as determined by atomic force microscopy
    127. Activity of acetone and methanol extract s from thirty-one medicinal plant species against herpes simplex virus types 1 and 2
    128. Adjuvant activity of ethanol extract of Hippophae rhamnoides leaves with inactivated rabies virus antigen
    129. Adjuvant activity of multimolecular complexes based on Glycyrrhiza glabra saponins, lipids, and influenza virus glycoproteins
    130. Adjuvant effect of Vernonia amygdalina leaf extract on host immune response to hepatitis B virus subunit vaccine
    131. Advance in studies on traditional Chinese medicines to treat infection with the hepatitis B virus and hepatitis C virus
    132. Advances and challenges in the synthesis of highly oxidised natural phenols with antiviral , antioxidant and cytotoxic activities
    133. Advances in developing therapies to combat Zika virus : current knowledge and future perspectives
    134. Advances in structure-assisted antiviral discovery for animal viral diseases
    135. Advances in the Clinical Treatment of viral Myocarditis
    136. Advances in the development of antiviral strategies against parvovirus B19
    137. Advances in the Development of antiviral Strategies against Parvovirus B19
    138. Aeginetia indica decoction inhibits hepatitis C virus life cycle
    139. African swine fever virus AP endonuclease is a redox-sensitive enzyme that repairs alkylating and oxidative damage to DNA
    140. AIDS-antiviral natural Products Research at The US National Cancer Institute
    141. Aikeqing decreases viral loads in SHIV89.6-infected Chinese rhesus macaques
    142. alkaloids as the natural anti-influenza virus agents: a systematic review
    143. Alkylated flavanone s from the Bark of Cryptocarya chartacea As Dengue virus NS5 Polymerase Inhibitors
    144. Allosteric inhibition of the NS2B-NS3 protease from dengue virus
    145. Almond skin extract s abrogate HSV-1 replication by blocking virus binding to the cell
    146. Alpinone exhibited immunomodulatory and antiviral activities in Atlantic salmon
    147. Amaryllidaceae alkaloids inhibit nuclear‐to‐cytoplasmic export of ribonucleoprotein (RNP) complex of highly pathogenic avian influenza virus H5N1
    148. Amelioration of influenza virus -induced reactive oxygen species formation by epigallocatechin gallate derived from green tea
    149. Amentoflavone Inhibits HSV-1 and ACV-Resistant Strain Infection by Suppressing viral Early Infection
    150. An active component containing pterodontic acid and pterodondiol isolated from Laggera pterodonta inhibits influenza A virus infection through the TLR7 …
    151. An anti-influenza virus activity-calibrated chemical standardization approach for quality evaluation of indigo natural is
    152. An antiviral drug screening system for enterovirus 71 based on an improved plaque assay: A potential high‐throughput method
    153. An Assay on the antiviral Activity of Mulberry Leaf extract [J]
    154. An evaluation of the antibacterial and antiviral activities of some bryophytes
    155. An evaluation of the antioxidant and antiviral action of extract s of rosemary and Provencal herbs
    156. An examination of the medicinal potential of Planchonella queenslandica: toxicity, antibacterial, and antiviral activities
    157. An examination of the medicinal potential of Scaevola spinescens: Toxicity, antibacterial, and antiviral activities
    158. An Experimental Research on the Anti-gland virus of Gangting
    159. An Experimental Study on antiviral Activity of Juhuangshangqing Buccal Tablet [J]
    160. An extract from Taxodium distichum targets hemagglutinin-and neuraminidase-related activities of influenza virus in vitro
    161. An extract ed Fraction of Pseudomonas Oleovorans Can Inhibit viral Entry and RNA Replication of Hepatitis C virus in Cell Culture
    162. An in-silico investigation of phytochemicals as antiviral agents against dengue fever
    163. An Initial Study on Mechanism of Zhong Yan Ⅱ in antiviral Activity Against Simian immunodeficiency virus [J]
    164. An overview of antiviral RNA silencing in plant : biogenesis, host–virus interaction and potential applications
    165. An overview on Zika virus and the importance of computational drug discovery
    166. Analysis of Antigenic and Genetic Characteristics of Influenza virus B Circulated in Sichuan Province in 2007
    167. Analysis of antioxidative and antiviral biomarkers β-amyrin, β-sitosterol, lupeol, ursolic acid in Guiera senegalensis leaves extract by validated HPTLC …
    168. Analysis of antiviral and chemoprotective effects of strawberry anthocyanins
    169. Analysis of antiviral Nucleoside Utilization in Our Hospital during 2006-2010
    170. Analysis of bioactive composites and antiviral activity of Iresine herbstii extract s against Newcastle disease virus in ovo
    171. Analysis of gene expression in human bronchial epithelial cells upon influenza virus infection and regulation by p38 mitogen‐activated protein kinase and c‐Jun‐N …
    172. Analysis of influence of baicalin joint resveratrol retention enema on the TNF-α, SIgA, IL-2, IFN-γ of rats with respiratory syncytial virus infection
    173. Analysis of secondary structure predictions of dengue virus type 2 NS2B/NS3 against crystal structure to evaluate the predictive power of the in silico methods
    174. Analysis of the antigenic and genetic characteristics of influenza virus subtype A3 circulated in Sichuan Province during 2006–2007
    175. Analysis on Epidemiological Characteristics of Influenza B virus in Shenzhen from 2009 to 2011 [J]
    176. Antagonism of baicalin on cell cyclical distribution and cell apoptosis in A549 cells infected with influenza A (H1N1) virus
    177. Anthracene-based inhibitors of dengue virus NS2B–NS3 protease
    178. Anthraquinone rich Cassia fistula pod extract induces IFIT1, antiviral protein
    179. Anti influenza virus activity of a red-fleshed potato anthocyanin
    180. Anti viral Medicinal plant s â â ‚¬ †œ An Ethnobotanical Approach
    181. Anti-Coxsackie virus B diterpenes from the roots of Illicium jiadifengpi
    182. Anti-Coxsackie virus B3 Norsesquiterpenoids from the Roots of Phyllanthus emblica
    183. Anti-dengue activity of Andrographis paniculata extract s and quantification of dengue viral inhibition by SYBR green reverse transcription polymerase chain …
    184. Anti-Dengue infectivity evaluation of bioflavonoid from Azadirachta indica by dengue virus serine protease inhibition
    185. Anti-DHAV-1 reproduction and immuno-regulatory effects of a flavonoid prescription on duck virus hepatitis
    186. Anti-enterovirus 71 activity screening of Taiwanese folk medicinal plant s and immune modulation of Ampelopsis brevipedunculata (Maxim.) Trautv against the virus
    187. Anti-equine arteritis virus activity of ethanolic extract and compounds from Origanum vulgare
    188. Anti-H1N1 virus , cytotoxic and Nrf2 activation activities of chemical constituents from Scutellaria baicalensis
    189. Anti-H5N1 virus FLAVONOIDS from Capparis sinaica Veill
    190. Anti-hepatitis B virus activities of astragaloside IV isolated from radix Astragali
    191. Anti-hepatitis B virus activities of friedelolactones from Viola diffusa Ging
    192. Anti-hepatitis B virus activities of Geranium carolinianum L. extract s and identification of the active components
    193. Anti-hepatitis B virus activities of triterpenoid saponin compound from potentilla anserine L.
    194. Anti-hepatitis B virus activity of chickweed [Stellaria media (L.) Vill.] extract s in HepG2. 2.15 cells
    195. Anti-Hepatitis B virus Activity of Chlorogenic Acid and Its Related Compounds
    196. Anti-Hepatitis B virus activity of FLAVONOIDS from Marchantia convoluta
    197. Anti-hepatitis B virus activity of new pyrimidine and adenine peptide nucleic acid analogues
    198. Anti-hepatitis B virus activity of swertisin isolated from Iris tectorum Maxim
    199. Anti-hepatitis B virus activity of wogonin in vitro and in vivo
    200. Anti-hepatitis B virus constituents from the stem bark of Streblus asper
    201. Anti-hepatitis B virus effects of the traditional Chinese herb Artemisia capillaris and its active enynes
    202. Anti-hepatitis B virus lignans from the root of Streblus asper
    203. Anti-Hepatitis B virus Norbisabolane Sesquiterpenoids from Phyllanthus acidus and the Establishment of Their Absolute Configurations Using Theoretical …
    204. Anti-hepatitis C virus activity of a crude extract from longan (Dimocarpus longan Lour.) leaves
    205. Anti-Hepatitis C virus Activity of Crude extract and Fractions of Entada africana in Genotype 1b Replicon Systems
    206. Anti-Hepatitis C virus Dinorditerpenes from the Roots of Flueggea virosa
    207. Anti-hepatitis C virus effect of citrus unshiu peel and its active ingredient nobiletin
    208. Anti-herpes simplex virus activities of monogalactosyl diglyceride and digalactosyl diglyceride from Clinacanthus nutans, a traditional Thai herbal medicine
    209. Anti-herpes simplex virus activity of alkaloids isolated from Stephania cepharantha
    210. Anti-Herpes Simplex virus and antibacterial activities of Graptopetalum paraguayense E. Walther leaf extract : a pilot study
    211. Anti-herpes simplex virus component isolated from Maclura cochinchinensis
    212. Anti-herpes simplex virus effect of an aqueous extract of propolis.
    213. Anti-Herpes Simplex virus Effect of Camellia sinesis, Echiumamoenum and Nerium oleander
    214. Anti-herpes simplex virus type 1 activity of Houttuynoid A, a flavonoid from Houttuynia cordata Thunb
    215. Anti-herpes simplex virus type 1 activity of specially selected groups of tannins
    216. Anti-herpes simplex virus type 2 activity from Rhinacanthus nasutus (Linn.) Kurz. extract s as affected by different extract ion solvents
    217. Anti-herpes simplex virus type-1 FLAVONOIDS and a new flavanone from the root of Limonium sinense
    218. Anti-herpes virus activities of Achyranthes aspera: an Indian ethnomedicine, and its triterpene acid
    219. Anti-herpes virus activities of bioactive fraction and isolated pure constituent of Mallotus peltatus: an ethnomedicine from Andaman Islands
    220. Anti-herpes virus activity of silibinin, the primary active component of Silybum marianum
    221. Anti-human immunodeficiency virus (anti-HIV) natural products with special emphasis on HIV reverse transcriptase inhibitors
    222. Anti-human immunodeficiency virus -1 activities of pratensein and pratensein glycoside from Alhaji maurorum and its parasite Cuscuta kotchiana
    223. Anti-human immunodeficiency virus -1 constituents of the bark of Poncirus trifoliata
    224. Anti-human immunodeficiency virus -type 1 activity of constituents fromJuglans mandshurica
    225. Anti-infective potential of catechins and their derivatives against viral hepatitis
    226. Anti-Infectivity against Herpes Simplex virus and Selected Microbes and Anti-Inflammatory Activities of Compounds Isolated from Eucalyptus globulus Labill.
    227. Anti-inflammatory and antiviral effects of Glossogyne tenuifolia
    228. Anti-inflammatory, antiviral and quantitative study of quercetin-3-O-β-D-glucuronide in Polygonum perfoliatum L.
    229. Anti-influenza A virus activity of a new dihydrochalcone diglycoside isolated from the Egyptian seagrass Thalassodendron ciliatum (Forsk.) den Hartog
    230. Anti-influenza A virus activity of dendrobine and its mechanism of action
    231. Anti-influenza A virus activity of epigallocatechin gallate [J]
    232. Anti-influenza A virus mechanism of three representative compounds from Flos Trollii via TLRs signaling pathways
    233. Anti-influenza activity of Alchemilla mollis extract : Possible virucidal activity against influenza virus particles
    234. Anti-influenza activity of betulinic acid from Zizyphus jujuba on influenza A/PR/8 virus
    235. Anti-influenza Chinese herbal Medicines and A Proposed Strategy to Search for Their Active Constituents Against Ebola virus
    236. Anti-influenza effect of the major FLAVONOIDS from Salvia plebeia R.Br. via inhibition of influenza H1N1 virus neuraminidase
    237. Anti-Influenza Nutraceuticals: antiviral and Anti-Inflammatory Effects
    238. Anti-influenza viral effects of honey in vitro: potent high activity of manuka honey
    239. Anti-Influenza viral FLAVONOIDS from Persicaria filiforme
    240. Anti-influenza virus (H1N1) effect of garlic oil in vitro
    241. Anti-Influenza virus Activities of Compounds from the Medicinal plant Bletillastriata
    242. Anti-influenza virus activities of FLAVONOIDS from the medicinal plant Elsholtzia rugulosa
    243. Anti-Influenza virus activity and constituents characterization of Paeonia delavayi extract s
    244. Anti-Influenza virus Activity and Phenolic Content of Pomegranate (Punica granatum L.) Peel extract and Fractions
    245. Anti-Influenza virus Activity of Adlay Tea Components
    246. Anti-influenza virus activity of biflavonoids
    247. Anti-influenza virus activity of Ginkgo biloba leaf extract s
    248. Anti-influenza virus activity of green tea by-products in vitro and efficacy against influenza virus infection in chickens
    249. Anti-Influenza virus Activity of plant Flavonoid, 5, 7, 4′-Trihydroxy-8-methoxyflavone , from the Roots of Scutellaria baicalensis and Enhancement of Its Activity by Drug …
    250. Anti-influenza virus activity of the ethanolic extract from Peperomia sui
    251. Anti-influenza virus Effect of Kening Granule [J]
    252. Anti-influenza virus effects of catechins: A molecular and clinical review
    253. Anti-influenza virus effects of elderberry juice and its fractions
    254. Anti-influenza virus effects of elderberry juice and its fractions
    255. Anti-influenza virus effects of the aqueous extract from Mosla scabra
    256. Anti-influenza-virus activity of total alkaloids from Commelina communis L.
    257. Anti-Japanese-encephalitis-viral effects of kaempferol and daidzin and their RNA-binding characteristics
    258. Anti-Mayaro virus activity of Cassia australis extract s (Fabaceae, Leguminosae)
    259. Anti-mumps virus activity by extract s of Mimosa pudica, a unique Indian medicinal plant
    260. Anti-respiratory passage virus of Chinese herbal medicine
    261. Anti-respiratory syncytial virus compounds from two endophytic fungi isolated from nigerian medicinal plant s
    262. Anti-tumor Activity Of Virulent Newcastle virus With Urtica pilulifera On Mammary Adenocarcinoma In mice
    263. Anti-tumor-promoting effects of isoFLAVONOIDS on Epstein–Barr virus activation and two-stage mouse skin carcinogenesis
    264. Anti-viral Activities of Ficus Benjamina and Lilium Candidum
    265. Anti-viral Activities of Oroxylum indicum extract s on Chikungunya virus Infection
    266. Anti-viral activities of selected Kenyan medicinal plant s against the hepatitis-B virus
    267. Anti-viral Activity Evaluation of Selected Medicinal plant s of Nigeria against Measles virus
    268. Anti-viral Activity of Indian plant s
    269. Anti-viral effects of medicinal plant s in the management of dengue: a systematic review
    270. Anti-viral properties and mode of action of standardized Echinacea purpurea extract against highly pathogenic avian influenza virus (H5N1, H7N7) and swine …
    271. Anti-virus activities of the extract and effective components isolated from Senecio cannabifolius less
    272. Anti-virus function of 5 kinds of total flavone ingredients in vitro
    273. Anti‐Hepatitis B virus Active Lactones from the Traditional Chinese Herb: Swertia mileensis
    274. Anti‑hepatitis B virus activity of Boehmeria nivea leaf extract s in human HepG2. 2.15 cells
    275. Anti‐hepatitis C virus activity of 3‐hydroxy caruilignan C from Swietenia macrophylla stems
    276. Anti‐hepatitis C virus compounds obtained from Glycyrrhiza uralensis and other Glycyrrhiza species
    277. Anti‐influenza virus activity of crude extract of Ribes nigrum L.
    278. Anti‐influenza virus agents: Synthesis and mode of action
    279. Anti‐influenza virus effects of cocoa
    280. Anti–Herpes Simplex virus Type-1 Activity and Phenolic Content of Crude Ethanol extract and Four Corresponding Fractions of Quercus brantii L Acorn
    281. Antibacterial and antiviral Value of the Genus Ganoderma P. Karst. Species (Aphyllophoromycetideae): A Review
    282. Antibacterial, antifungal and antiviral activity of propolis of different geographic origin
    283. Antibacterial, antifungal and antiviral bioactivities of selected Helichrysum species
    284. Antibacterial, antifungal, and antiviral activities of African medicinal plant s
    285. Antibacterial, antifungal, and antiviral activities of some flavonoids
    286. Anti-influenza virus effects of the aqueous extract from Mosla scabra
    287. Anti-influenza-virus activity of total alkaloids from Commelina communis L.
    288. Anti-Japanese-encephalitis-viral effects of kaempferol and daidzin and their RNA-binding characteristics
    289. Anti-Mayaro virus activity of Cassia australis extract s (Fabaceae, Leguminosae)
    290. Anti-mumps virus activity by extract s of Mimosa pudica, a unique Indian medicinal plant
    291. Anti-respiratory passage virus of Chinese herbal medicine
    292. Anti-respiratory syncytial virus compounds from two endophytic fungi isolated from nigerian medicinal plant s
    293. Anti-tumor Activity Of Virulent Newcastle virus With Urtica pilulifera On Mammary Adenocarcinoma In mice
    294. Anti-tumor-promoting effects of isoFLAVONOIDS on Epstein–Barr virus activation and two-stage mouse skin carcinogenesis
    295. Anti-viral Activities of Ficus Benjamina and Lilium Candidum
    296. Anti-viral Activities of Oroxylum indicum extract s on Chikungunya virus Infection
    297. Anti-viral activities of selected Kenyan medicinal plant s against the hepatitis-B virus
    298. Anti-viral Activity Evaluation of Selected Medicinal plant s of Nigeria against Measles virus
    299. Anti-viral Activity of Indian plant s
    300. Anti-viral effects of medicinal plant s in the management of dengue: a systematic review
    301. Anti-viral properties and mode of action of standardized Echinacea purpurea extract against highly pathogenic avian influenza virus (H5N1, H7N7) and swine …
    302. Anti-virus activities of the extract and effective components isolated from Senecio cannabifolius less
    303. Anti-virus function of 5 kinds of total flavone ingredients in vitro
    304. Anti‐Hepatitis B virus Active Lactones from the Traditional Chinese Herb: Swertia mileensis
    305. Anti‑hepatitis B virus activity of Boehmeria nivea leaf extract s in human HepG2. 2.15 cells
    306. Anti‐hepatitis C virus activity of 3‐hydroxy caruilignan C from Swietenia macrophylla stems
    307. Anti‐hepatitis C virus compounds obtained from Glycyrrhiza uralensis and other Glycyrrhiza species
    308. Anti‐influenza virus activity of crude extract of Ribes nigrum L.
    309. Anti‐influenza virus agents: Synthesis and mode of action
    310. Anti‐influenza virus effects of cocoa
    311. Anti–Herpes Simplex virus Type-1 Activity and Phenolic Content of Crude Ethanol extract and Four Corresponding Fractions of Quercus brantii L Acorn
    312. Antibacterial and antiviral Value of the Genus Ganoderma P. Karst. Species (Aphyllophoromycetideae): A Review
    313. Antibacterial, antifungal and antiviral activity of propolis of different geographic origin
    314. Antibacterial, antifungal and antiviral bioactivities of selected Helichrysum species
    315. Antibacterial, antifungal, and antiviral activities of African medicinal plant s
    316. Antibacterial, antifungal, and antiviral activities of some flavonoids
    317. Antibacterial, Antifungal, and antiviral Properties of Medical plant s
    318. Antibacterial, antiviral and antifungal activity of essential oils: Mechanisms and applications
    319. Antibacterial, antiviral and antioxidant activities of aerial part extract s of Peganum harmala L. grown in Tunisia
    320. Antibacterial, antiviral , and antifungal properties of wines and winery byproducts in relation to their flavonoid content
    321. Antibacterial, antiviral , antiproliferative and apoptosis‐inducing properties of Brackenridgea zanguebarica (Ochnaceae)
    322. Antibacterial, cytotoxicity and antiviral activities of Asplenium nidus
    323. Antibiofilm and antiviral Potential of Leaf extract s from Moringa oleifera and Rosemary (Rosmarinus officinalis Lam.)
    324. Antibiotic prescribing to the inpatients diagnosed with Malaria and viral fever in two tertiary care hospitals in Madhya Pradesh India
    325. Anticancer and antiviral activities of Youngia japonica (L.) DC (Asteraceae, Compositae)
    326. Anticancer and antiviral activity of marine algae.
    327. Anticancer and antiviral Effects and Inactivation of S-Adenosyl-l-homocysteine Hydrolase with 5′-Carboxaldehydes and Oximes Synthesized from Adenosine and Sugar …
    328. Anticancer and antiviral estimation of three Ulmus pravifolia extract s and their chemical constituents
    329. Anticancer, antiviral , antibacterial, and antifungal properties in microalgae
    330. Antidengue potential of leaf extract s of Pavetta tomentosa and Tarenna asiatica (Rubiaceae) against dengue virus and its vector Aedes aegypti (Diptera …
    331. ANTIHEPATITIS C virus ACTIVITY OF INDONESIAN MAHOGANY (TOONA SURENI)
    332. Antiherpes virus activity of extract s from the medicinal plant Geranium sanguineum L.
    333. Antiherpetic activities of FLAVONOIDS against herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2)in vitro
    334. Antimicrobial and antiviral activities of grape seed extract s
    335. Antimicrobial and antiviral Activities of Two Seed Oil Samples of Cucurbita pepo L. and Their Fatty Acid Analysis
    336. Antimicrobial and antiviral activity-guided fractionation from Scutia buxifolia Reissek extract s
    337. Antimicrobial and antiviral effects of essential oils from selected Umbelliferae and Labiatae plant s and individual essential oil components
    338. Antimicrobial and antiviral properties of different types of propolis
    339. Antimicrobial and antiviral screening of novel indole carboxamide and propanamide derivatives
    340. Antimicrobial studies of Ficus benghalensis and Ficus racemosa on pathogenic viral diseases
    341. Antimicrobial, anthelmintic, and antiviral activity of plant s traditionally used for treating infectious disease in the similipal biosphere reserve, Odisha, India
    342. Antimicrobial, antioxidant, and antiviral activities of Retama raetam (Forssk.) Webb flowers growing in Tunisia
    343. Antimicrobial, antiviral activity and GC-MS analysis of essential oil extract ed from Achillea fragrantissima plant growing in Sinai Peninsula
    344. Antimicrobial, antiviral and antioxidant activities of “água-mel” from Portugal
    345. Antimicrobial, antiviral and immunomodulatory activity studies of Pelargonium sidoides (EPs® 7630) in the context of health promotion
    346. Antioxidant activities of extract s from five anti-viral medicinal plant s
    347. Antioxidant Activity of antiviral Proteins from Celosia cristata
    348. Antioxidant and anti-hepatitis c viral activities of commercial milk thistle food supplements
    349. Antioxidant and antiviral activities of lipophilic epigallocatechin gallate (EGCG) derivatives
    350. Antioxidant and antiviral activities of the aqueous alcoholic leaf extract of Boscia angustifolia A. Rich.(Capparaceae) and its major component’ombuin’
    351. Antioxidant and antiviral properties of Pseudopiptadenia contorta (Leguminosae) and of quebracho (Schinopsis sp.) extract s
    352. Antioxidant Status in Human immunodeficiency virus Infection in Different Clinical Conditions
    353. Antioxidant treatment regulates the humoral immune response during acute viral infection
    354. Antioxidant, antibacterial and antiviral properties of Goniothalamus umbrosus leaves methanolic extract
    355. Antioxidant, antibacterial, and antiviral effects of Lactuca sativa extract s
    356. Antioxidative and antiviral Properties of Flowering Cherry Fruits (Prunus serrulata L. var. spontanea)
    357. Antiplasmodial, anti-chikungunya virus and antioxidant activities of 64 endemic plant s from the Mascarene Islands
    358. Antiprotozoal, antiviral and cytotoxic properties of the Nigerian Mushroom, Hypoxylon fuscum Pers. Fr.(Xylariaceae)
    359. Antiretroviral agents against human immunodeficiency virus : an overview of current drugs and new perspectives
    360. Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP‐1 translocation, and …
    361. Antitumor Activities of Secondary Metabolites from Marine Microbe Stress Responses to virus Infection
    362. antiviral abilities of Curcuma kwangsiensis ingredients against grouper iridoviral infection in vitro and in vivo
    363. antiviral ability of Kalanchoe gracilis leaf extract against enterovirus 71 and coxsackievirus A16
    364. antiviral action of hydromethanolic extract of geopropolis from Scaptotrigona postica against antiherpes simplex virus (HSV-1)
    365. antiviral actions of flavanoid-derived compounds on dengue virus type-2
    366. antiviral activities of aerial subsets of Artemisia species against Herpes Simplex virus type 1 (HSV1) in vitro
    367. antiviral activities of atractylon from Atractylodis Rhizoma
    368. antiviral activities of biflavonoids
    369. antiviral activities of compounds from aerial parts of Salvia plebeia R. Br
    370. antiviral activities of Cucumis metuliferus fruits alkaloids on Infectious Bursal Disease virus (IBDV)
    371. antiviral Activities of Curcuma Genus against Hepatitis C virus
    372. antiviral activities of extract s and phenolic components of two Spondias species against dengue virus
    373. antiviral activities of extract s and selected pure constituents of Ocimum basilicum
    374. antiviral activities of extract s of Euphorbia hirta L. against HIV-1, HIV-2 and SIVmac251
    375. antiviral activities of extremophilic actinomycetes extract s from Kazakhstan’s unique ecosystems against influenza virus es and paramyxovirus es
    376. antiviral activities of FLAVONOIDS and organic acid from Trollius chinensis Bunge
    377. antiviral activities of FLAVONOIDS isolated from the bark of Rhus verniciflua stokes against fish pathogenic virus es In Vitro
    378. antiviral activities of hedera helix containing hederasaponin B and phyllanthus urinaria containing corilagin against enterovirus infections
    379. antiviral Activities of Hibiscus sabdariffa L. Tea extract Against Human Influenza A virus Rely Largely on Acidic pH but Partially on a Low-pH-Independent …
    380. antiviral activities of hydroxylated flavone s on feline foamy viral proliferation
    381. antiviral activities of hypericin
    382. antiviral activities of Indonesian medicinal plant s in the East Java region against hepatitis C virus
    383. antiviral Activities of L-FMAUS, a new L-FMAU derivative, Against Hepatitis B virus
    384. antiviral activities of Lonicera japonica Thunb. Components against grouper iridovirus in vitro and in vivo
    385. antiviral activities of medicinal herbs traditionally used in southern mainland China
    386. antiviral activities of medicinal plant s of southern Nepal
    387. antiviral activities of mulberry (Morus alba) juice and seed against influenza virus es
    388. antiviral activities of natural compounds derived from traditional chinese medicines against porcine circovirus type 2 (PCV2)
    389. antiviral activities of plant s occurring in the state of Minas Gerais, Brazil: Part 2. Screening Bignoniaceae species
    390. antiviral activities of purified compounds from Youngia japonica (L.) DC (Asteraceae, Compositae)
    391. antiviral activities of selected Chinese medicinal plant s
    392. antiviral activities of several oral traditional Chinese medicines against influenza virus es
    393. antiviral Activities of Silymarin and Derivatives
    394. antiviral activities of some Ethiopian medicinal plant s used for the treatment of dermatological disorders
    395. antiviral Activities of the Aqueous, Ethanolic and Methanolic extract s of Diospyros Mespiliformis leaf on some pathogenic Avian virus es.
    396. antiviral activity against herpes simplex virus of lipoic acid
    397. antiviral Activity Against Infectious Bronchitis virus and Bioactive Components of Hypericum perforatum L.
    398. antiviral activity and Antioxidant role Bedd in NDV induced ox
    399. antiviral activity and chemical composition of European and Egyptian propolis
    400. antiviral activity and chemical compositions of extract s from Myrica rubra
    401. antiviral Activity and Constituents of the Nepalese Medicinal plant Astilbe rivularis.
    402. antiviral activity and cytotoxicity of the lipophilic extract s of various edible plant s and their fatty acids
    403. antiviral activity and mode of action of a peptide isolated from Sorghum bicolor
    404. antiviral activity and mode of action of propolis extract s and selected compounds
    405. antiviral Activity and Molecular Targets of plant natural Products Against Avian Influenza virus
    406. antiviral Activity and Phytochemical Analysis of Ailanthus Excelsa Roxb Bark
    407. antiviral activity and possible mechanism of action of constituents identified in Paeonia lactiflora root toward human rhinovirus es
    408. antiviral activity and possible mode of action of ellagic acid identified in Lagerstroemia speciosa leaves toward human rhinovirus es
    409. antiviral activity in vitro and in vivo of natural FLAVONOIDS isolated from Heliotropium sinuatum against infectious salmon anemia virus (ISAV)
    410. antiviral activity of [1, 2, 3] triazolo [4, 5-d] pyrimidin-7 (6H)-ones against chikungunya virus targeting the viral capping nsP1
    411. antiviral activity of 3 (2H)-and 6-chloro-3 (2H)-isoflavenes against highly diverged, neurovirulent vaccine-derived, type2 poliovirus sewage isolates
    412. antiviral activity of 3, 4′-dihydroxyflavone on influenza a virus
    413. antiviral activity of 5, 6, 7-trimethoxyflavone and its potentiation of the antiherpes activity of acyclovir.
    414. antiviral Activity of a Arisaema Tortuosum Leaf extract and Some of its Constituents against Herpes Simplex virus Type 2
    415. antiviral activity of a nanoemulsion of polyprenols from ginkgo leaves against influenza A H3N2 and hepatitis B virus in vitro
    416. antiviral activity of a synthesized shikonin ester against influenza a (H1N1) virus and insights into its mechanism
    417. antiviral activity of a zymolytic grain based extract on human immunodeficiency virus type 1 In Vitro
    418. antiviral activity of Acacia nilotica against Hepatitis C virus in liver infected cells
    419. antiviral activity of African medicinal plant s
    420. antiviral activity of Ageratina havanensis and major chemical compounds from the most active fraction
    421. antiviral Activity of Alhagi maurorum Medik’s Methanolic extract on Foot and Mouth Disease virus (FMDV) in Cell Cultures
    422. antiviral activity of Aloe hijazensis against some haemagglutinating virus es infection and its phytoconstituents
    423. antiviral Activity of Aloe hijazensis against Some Haemagglutinating virus es Infection and its Phytoconstituents
    424. antiviral activity of Alpinia katsumadai extract s against rotavirus es
    425. antiviral activity of Alternanthera Philoxeroides effective fractions extract s against virus A H3N2
    426. antiviral activity of antofine from Cynanchum komarovii
    427. antiviral activity of Arctigenin against Newcastle Disease virus in vitro
    428. antiviral Activity of Aspalathus linearis against Human Influenza virus
    429. antiviral activity of baicalein and quercetin against the Japanese encephalitis virus
    430. antiviral activity of baicalin against influenza A (H1N1/H3N2) virus in cell culture and in mice and its inhibition of neuraminidase
    431. antiviral activity of baicalin against influenza virus H1N1-pdm09 is due to modulation of NS1-mediated cellular innate immune responses
    432. antiviral Activity of Benzoic Acid Derivative NC-5 Against Influenza A virus and Its Neuraminidase Inhibition
    433. antiviral activity of betacyanins from red pitahaya (Hylocereus polyrhizus) and red spinach (Amaranthus dubius) against dengue virus type 2 (GenBank accession no …
    434. antiviral activity of Bifidobacterium adolescentis SPM 0214 against herpes simplex virus type 1
    435. antiviral activity of Bignoniaceae species occurring in the State of Minas Gerais (Brazil): part 1
    436. antiviral Activity of Bioflavonoid against Dengue virus Type-2
    437. antiviral activity of Bolivian plant extract s
    438. antiviral Activity of Cananga odorata Against Hepatitis B virus
    439. antiviral Activity of Cardiospermum Halicacabum L. extract against Coinfecting Agents HIV and HBV
    440. antiviral Activity of Cassia Alata and Cosmos Caudatus Leaf extract to Dengue virus Serotype-2 New Guinea C Strain in Huh7-it1 Cell
    441. antiviral activity of Ceiba pentandra and Eugenia uniflora leaf extract s to dengue virus serotype-2 in Huh 7it-1 cell line
    442. antiviral activity of characterized extract s from Echinacea spp.(Heliantheae: Asteraceae) against herpes simplex virus (HSV-I)
    443. antiviral activity of chlorogenic acid against influenza A (H1N1/H3N2) virus and its inhibition of neuraminidase
    444. antiviral activity of Chongkukjang extract s against influenza A virus in vitro and in vivo
    445. antiviral activity of chrysin derivatives against coxsackievirus B3 in vitro and in vivo
    446. antiviral activity of Cleome rosea extract s from field-grown plant s and tissue culture-derived materials against acyclovir-resistant Herpes simplex virus es type 1 (ACVr …
    447. antiviral activity of compounds isolated from plant s
    448. antiviral Activity of Constituents Identified in Propolis against Human Rhinovirus and their Possible Mode of Action
    449. antiviral activity of Conyza canadensis (L.) Cronquist extract s grown in Tunisia
    450. antiviral activity of Corylus heterophylla fisch against porcine epidemic diarrhea virus infection
    451. antiviral activity of crude extract s from Commiphora swynnertonii against Newcastle disease virus in ovo
    452. antiviral activity of crude extract s of Eugenia jambolana Lam. against highly pathogenic avian influenza (H5N1) virus
    453. antiviral activity of crude hydroethanolic extract from Schinus terebinthifolia against Herpes simplex virus Type 1
    454. antiviral Activity of Cynometra ramiflora Linn Leaves extract Against Replication of Dengue virus Serotype 2 on Huh 7.5 Cell In Vitro
    455. antiviral activity of Dianthus superbusn L. against hepatitis B virus in vitro and in vivo
    456. antiviral Activity of Dicrocephala Integrifolia (Kuntze) Against Herpes Simplex Type-1 virus : An in vitro Study
    457. antiviral activity of Distictella elongata (Vahl) Urb. (Bignoniaceae), a potentially useful source of anti‐dengue drugs from the state of Minas Gerais, Brazil
    458. antiviral ACTIVITY OF ECHINACEA (ECHINACEA PURPUREA) REZA MOHAMMADHASSAN, SAEEDEH AKHAVAN 2, 3, AIDA MAHMOUDI, ATIEH …
    459. antiviral activity of ethanol extract of Lophatherum gracile against respiratory syncytial virus infection
    460. antiviral activity of ethanol extract s of Ficus benjamina and its fractions in vitro
    461. antiviral activity of ethanol extract s of Ficus binjamina and Lilium candidum in vitro
    462. antiviral activity of Eucalyptus camaldulensis leaves ethanolic extract on herpes virus es infection
    463. antiviral activity of Euphorbia helioscopia extract
    464. antiviral Activity of Euphorbia Lectin Against Herpes Simplex virus 1 and its Antiproliferative Activity Against Human Cancer Cell-Line. J Antivir Antiretrovir 8 …
    465. antiviral Activity of Extracellular Polysaccharide from Porphyridium sp. against Respiratory Syncytial virus (RSV).
    466. antiviral activity of extract s from Brazilian seaweeds against herpes simplex virus
    467. antiviral Activity of extract s from Wild Grasses against Epstein-Barr virus and Induction of Apoptosis in EBV-positive Lymphoblastoid Cells
    468. antiviral activity of Faramea bahiensis leaves on dengue virus type-2 and characterization of a new antiviral flavanone glycoside
    469. antiviral Activity of Faramea hyacinthina and Faramea truncata Leaves on Dengue virus Type‐2 and Their Major Compounds
    470. antiviral activity of few selected indigenous plant s against Bovine Herpes virus -1
    471. antiviral activity of five Asian medicinal pant crude extract s against highly pathogenic H5N1 avian influenza virus
    472. antiviral activity of five filamentous cyanobacteria against coxsackievirus B3 and rotavirus
    473. antiviral activity of flavone s and potentiation by ascorbate
    474. antiviral activity of FLAVONOIDS present in aerial parts of Marcetia taxifolia against Hepatitis B virus , Poliovirus , and Herpes Simplex virus in vitro
    475. antiviral activity of Flos verbasci infusion against influenza and Herpes simplex virus es.
    476. antiviral activity of four types of bioflavonoid against dengue virus type-2
    477. antiviral activity of Fridericia formosa (Bureau) LG Lohmann (Bignoniaceae) extract s and constituents
    478. antiviral activity of galangin isolated from the aerial parts of Helichrysum aureonitens
    479. antiviral activity of geopropolis extract from Scaptotrigona aff. postica against Rubella virus .
    480. antiviral activity of herbal extract s against the hepatitis A virus
    481. antiviral activity of hop constituents against a series of DNA and RNA virus es
    482. antiviral activity of hydroalcoholic extract from Eupatorium perfoliatum L. against the attachment of influenza A virus
    483. antiviral activity of Illicium verum Hook. f. extract s against grouper iridovirus infection
    484. antiviral activity of Isatidis Radix derived glucosinolate isomers and their breakdown products against influenza A in vitro/ovo and mechanism of action
    485. antiviral Activity of Isoorientin against Respiratory Syncytial virus in Vitro and in Vivo
    486. antiviral activity of Jinchai capsule against influenza virus
    487. antiviral activity of Justicia gendarussa Burm. f. leaves against HIV-infected MT-4 cells
    488. antiviral activity of Ladania067, an extract from wild black currant leaves against influenza A virus in vitro and in vivo
    489. antiviral Activity of Lady’s Mantle (Alchemilla vulgaris L.) extract s against Orthopoxvirus es
    490. antiviral Activity of latex from Ficus nitida against plant virus es
    491. antiviral ACTIVITY OF LATHAKARANJA (CAESALPINIA CRISTA L.) CRUDE extract S ON SELECTED ANIMAL virus ES
    492. antiviral activity of leaf-bud gum-resin of Tarenna asiatica
    493. antiviral activity of leaves extract s of Marrubium alysson L
    494. antiviral activity of luteolin against Japanese encephalitis virus
    495. antiviral activity of maca (Lepidium meyenii) against human influenza virus
    496. antiviral activity of medicinal plant extract s
    497. antiviral activity of medicinal plant s of Nilgiris
    498. antiviral activity of Mentha spicata Linn. extract s against porcine parvovirus in vitro
    499. antiviral activity of metal chelates of caffeic acid and similar compounds towards herpes simplex, VSV-Ebola pseudotyped and vaccinia virus es
    500. antiviral activity of Momordica charantia: a preliminary study on in vitro anti herpes simplex virus
    501. antiviral activity of Myracrodruon urundeuva against rotavirus
    502. antiviral activity of myticin C peptide from mussel: an ancient defense against herpesvirus es
    503. antiviral activity of natural and semi-synthetic chromone alkaloids
    504. antiviral activity of natural occurring FLAVONOIDS in vitro
    505. antiviral activity of natural phloroglucinols and their analogues
    506. antiviral activity of nobiletin against chikungunya virus in vitro
    507. antiviral activity of obtained extract s from different parts of cupressus sempervirens against Herpes Simplex virus Type 1
    508. antiviral activity of oroxylin A against coxsackievirus B3 alleviates virus -induced acute pancreatic damage in mice
    509. antiviral activity of Panamanian plant extract s
    510. antiviral activity of Paulownia tomentosa against enterovirus 71 of hand, foot, and mouth disease
    511. antiviral activity of Petiveria alliacea against the bovine viral diarrhea virus
    512. antiviral activity of phenanthrenes from the medicinal plant Bletilla striata against influenza A virus
    513. antiviral activity of phytochemicals: a comprehensive review
    514. antiviral activity of phytochemicals: a current perspective
    515. antiviral activity of pinocembrin against Zika virus replication
    516. antiviral activity of plant components. 1st communication: FLAVONOIDS (author’s transl)
    517. antiviral activity of plant flavonoid, 5, 7, 4′-trihydroxy-8-methoxyflavone , from the roots of Scutellaria baicalensis against influenza A (H3N2) and B virus es
    518. antiviral activity of plant POLYPHENOLS
    519. antiviral activity of plant ago major extract s and related compounds in vitro
    520. antiviral activity of plant s and their isolated bioactive compounds: An update
    521. antiviral Activity of Polymethoxylated flavone s from “Guangchenpi”, the Edible and Medicinal Pericarps of Citrus reticulata ‘Chachi’
    522. antiviral activity of POLYPHENOLS extract s from Daucus carota against Herpes simplex virus type 1
    523. antiviral activity of Poncirus trifoliata seed extract against oseltamivir-resistant influenza virus
    524. antiviral activity of propolis special extract GH 2002 against Varicella zoster virus in vitro
    525. antiviral activity of quercetin 7-rhamnoside against porcine epidemic diarrhea virus
    526. antiviral activity of quercetin-3-β-OD-glucoside against Zika virus infection
    527. antiviral activity of Quercus persica L.: high efficacy and low toxicity
    528. antiviral activity of resveratrol against human and animal virus es
    529. antiviral activity of ribavirin and favipiravir against human astrovirus es
    530. antiviral activity of root extract s from Tagetes minuta against Herpes simplex virus (HSV-1)
    531. antiviral activity of Sambucus FormosanaNakai ethanol extract and related phenolic acid constituents against human coronavirus NL63
    532. antiviral activity of selected FLAVONOIDS against Chikungunya virus
    533. antiviral activity of seven iridoids, three saikosaponins and one phenylpropanoid glycoside extract ed from Bupleurum rigidum and Scrophularia scorodonia
    534. antiviral activity of shikonin ester derivative PMM-034 against enterovirus 71 in vitro
    535. antiviral activity of silymarin against chikungunya virus
    536. antiviral activity of silymarin against Mayaro virus and protective effect in virus -induced oxidative stress
    537. antiviral Activity of SIO2–Polyphenol Composites Prepared Mechanochemically from plant Raw Materials
    538. antiviral activity of Solanum paniculatum extract and constituents
    539. antiviral activity of some plant oils against herpes simplex virus type 1 in Vero cell culture
    540. antiviral activity of some plant s used in Nepalese traditional medicine
    541. antiviral activity of some South American medicinal plant s
    542. antiviral activity of some Tunisian medicinal plant s against Herpes simplex virus type 1
    543. antiviral activity of ST081006 against the dengue virus
    544. antiviral activity of subcritical water extract of Brassica juncea against influenza virus A/H1N1 in nonfat milk
    545. antiviral activity of substituted homoisoFLAVONOIDS on enterovirus es
    546. antiviral activity of sulfated polysaccharide of Adenanthera pavonina against poliovirus in HEp-2 cells
    547. antiviral activity of sulfated polysaccharides carrageenan from some marine seaweeds
    548. antiviral activity of Terminalia
    549. antiviral activity of ternatin and meliternatin, 3-methoxyflavone s from species of Rutaceae
    550. antiviral activity of the crude n-hexane extract from leaves of Piper lepturum var. angustifolium (C. DC.) Yunck.(Piperaceae)
    551. antiviral activity of the dichloromethane extract s from Artocarpus heterophyllus leaves against hepatitis C virus
    552. antiviral Activity of the Essential Oil of Melaleuca alternifolia (Maiden amp; Betche) Cheel (Tea Tree) Against Tobacco Mosaic virus
    553. antiviral Activity of the Four Monomers of Isatis Tinctoria L Against Coxsackievirus B_3 in vitro
    554. antiviral activity of the fruit extract of Cucumis metuliferus E. Meye (Curcubitaceae) in chicks
    555. antiviral activity of the infusion (SHS‐174) from flowers of Sambucus nigra L., aerial parts of Hypericum perforatum L., and roots of Saponaria officinalis L. against …
    556. antiviral activity of the oseltamivir and Melissa officinalis L. essential oil against avian influenza A virus (H9N2)
    557. antiviral activity of the sea cucumber tegument extract (Pattalus mollis) on human rotavirus A (RVA)
    558. antiviral Activity of the Sesquiterpene Lactones from Centipeda minima against Influenza a virus in vitro
    559. antiviral activity of the volatile oils of Melissa officinalis L. against Herpes simplex virus type-2
    560. antiviral activity of theaflavin digallate against herpes simplex virus type 1
    561. antiviral activity of total flavonoid extract s from Selaginella moellendorffii Hieron against coxsackie virus B3 in vitro and in vivo
    562. antiviral activity of traditional Chinese medicinal plant s Dryopteris crassirhizoma and Morus alba against dengue virus
    563. antiviral Activity of Traditional Medicinal plant s against Human Influenza virus es: Potent Anti-Influenza Activity of Aspalathus linearis
    564. antiviral activity of Trichilia catigua bark extract s for herpesvirus and poliovirus
    565. antiviral activity of uridine derivatives of 2-deoxy sugars against tick-borne encephalitis virus
    566. antiviral activity of Veronica persica Poir. on herpes virus infection
    567. antiviral Activity of Vicoa indica Against Herpes Simplex virus
    568. antiviral activity of Zanthoxylum species against influenza virus
    569. antiviral activity on hantavirus and apoptosis of VERO cells of natural and semi-synthetic compounds from Heliotropium filifolium Resin
    570. antiviral activity-guided fractionation from Araucaria angustifolia leaves extract
    571. antiviral agents against African swine fever virus
    572. antiviral agents against Ebola virus infection: repositioning old drugs and finding novel small molecules
    573. antiviral agents from natural sources
    574. antiviral agents from selected Chinese herbal medicines
    575. antiviral agents in development for Zika virus infections
    576. antiviral agents of plant origin. Antiherpetic activity of acacetin
    577. antiviral Agents, RNA virus es (Other than HIV), and Orthopoxvirus es
    578. antiviral amentoflavone from Selaginella sinensis
    579. antiviral and Antibacterial Screening of Some Nigerian Medicinal plant extract s
    580. antiviral and antimicrobial activities of Paeonia lactiflora root constituents and structurally related compounds against human rhinovirus and gastrointestinal bacteria
    581. antiviral and antimicrobial assessment of some selected flavonoids
    582. antiviral and antimicrobial evaluation of some heterocyclic compounds from Turkish plant s
    583. antiviral and antimicrobial profiles of selected isoquinoline alkaloids from Fumaria and Corydalis species
    584. antiviral and antioxidant activities of FLAVONOIDS of Ficus virens: Experimental and theoretical investigations
    585. antiviral and antioxidant activities of sulfated galactomannans from plant s of Caatinga Biome
    586. antiviral and antioxidant activities of two medicinal plant s
    587. antiviral and Antioxidant Activity of a Hydroalcoholic extract from Humulus lupulus L.
    588. antiviral and antioxidant activity of FLAVONOIDS and proanthocyanidin s from Crataegus sinaica
    589. antiviral and antioxidant properties of echinochrome a
    590. antiviral and antiparasitic activities of clovamide: the major constituent of Dichrostachys cinerea (L.) wight et arn
    591. antiviral and antituberculous activity of Helichrysum melanacme constituents
    592. antiviral and antitumor activity of licorice root extract s
    593. antiviral and cytotoxic activities of anthraquinones isolated from Cassia roxburghii Linn. leaves
    594. antiviral and cytotoxic activities of some Indonesian plant s
    595. antiviral and cytotoxic evaluation of coumarins from Prangos ferulacea
    596. antiviral and immune stimulant activities of glycyrrhizin against duck hepatitis virus
    597. antiviral and immunomodulatory effect of a lyophilized extract of Capparis spinosa L. buds
    598. antiviral and immunomodulatory effects of Norantea brasiliensis choisy on dengue virus -2
    599. antiviral and immunomodulatory effects of POLYPHENOLS on macrophages infected with dengue virus serotypes 2 and 3 enhanced or not with antibodies
    600. antiviral and immunomodulatory Properties of Meliaceae Family
    601. antiviral and immunostimulant activities of Andrographis paniculata
    602. antiviral and therapeutic uses of medicinal plant s and their derivatives against dengue virus es
    603. antiviral and virucidal activities of Duabanga grandiflora leaf extract against Pseudorabies virus in vitro
    604. antiviral and virucidal activities of natural products
    605. antiviral biFLAVONOIDS from Radix Wikstroemiae (Liaogewanggen)
    606. antiviral Chinese medicinal herbs against respiratory syncytial virus
    607. antiviral Chromones from the Stem of Cassia siamea
    608. antiviral clerodane diterpenoids from Dodonaea viscosa
    609. antiviral compounds in extract s of Korean seaweeds: Evidence for multiple activities
    610. antiviral dicaffeoyl derivatives from Elephantopus scaber
    611. antiviral drug disposition and natural health products: risk of therapeutic alteration and resistance
    612. antiviral drug rodopes: evaluation of wound healing activity.
    613. antiviral drug therapy-exploiting medicinal plant s
    614. antiviral drugs
    615. antiviral drugs fit for a purpose
    616. antiviral drugs that target cellular proteins may play major roles in combating HIV resistance
    617. antiviral Effect and Mechanism of Scutellaria Baicalensis Georgi [J]
    618. antiviral effect assay of aqueous extract of EchiumAmoenum-Lagainst HSV-1
    619. antiviral effect of 7-(4-benzimidazole-butoxy)-coumarin on rhabdoviral clearance via Nrf2 activation regulated by PKCα/β phosphorylation
    620. antiviral effect of a polysaccharide from Sclerotium glucanicum towards herpes simplex virus type 1 infection
    621. antiviral Effect of Alternanthera Philoxeroides Microemulsion on Coxsackie virus Group B_3 in Vitro
    622. antiviral effect of aqueous extract s from species of the Lamiaceae family against Herpes simplex virus type 1 and type 2 in vitro
    623. antiviral effect of Archidendron pauciflorum leaves extract to hepatitis C virus : An in vitro study in JFH-1 strain
    624. antiviral effect of baicalin phospholipid complex against duck hepatitis A virus type 1
    625. antiviral effect of catechins in green tea on influenza virus
    626. antiviral effect of Dureping Injection in mice infected by influenza virus FM1 strain [J]
    627. antiviral effect of epigallocatechin gallate on enterovirus 71
    628. antiviral effect of Epimedium koreanum extract
    629. antiviral effect of FLAVONOIDS on human virus es
    630. antiviral effect of FLAVONOIDS on the dengue virus
    631. antiviral effect of flavonol glycosides isolated from the leaf of Zanthoxylum piperitum on influenza virus
    632. antiviral effect of Guazuma ulmifolia and Stryphnodendron adstringens on poliovirus and bovine herpesvirus
    633. antiviral effect of Korean red ginseng extract and ginsenosides on murine norovirus and feline calicivirus as surrogates for human norovirus
    634. antiviral effect of methylated flavonol isorhamnetin against influenza
    635. antiviral effect of octyl gallate against DNA and RNA virus es
    636. antiviral Effect of Phyllanthus amarus Leaf extract against Newcastle Disease virus in Broilers
    637. antiviral effect of Phyllanthus nanus ethanolic extract against hepatitis B virus (HBV) by expression microarray analysis
    638. antiviral effect of phytochemicals from medicinal plant s: Applications and drug delivery strategies
    639. antiviral effect of polyphenol rich plant extract s on herpes simplex virus type 1
    640. antiviral Effect of Pterocarpus indicus Willd Leaves extract Against Replication of Dengue virus (DENV) In Vitro
    641. antiviral effect of resveratrol in ducklings infected with virulent duck enteritis virus
    642. antiviral effect of resveratrol in piglets infected with virulent Pseudorabies virus
    643. antiviral effect of saikosaponin B2 in combination with daclatasvir on NS5A resistance-associated substitutions of hepatitis C virus
    644. antiviral Effect of Sub Fraction Cassia alata Leaves extract to Dengue virus Serotype-2 strain New Guinea C in Human Cell Line Huh-7 it-1
    645. antiviral effect of the extract of culture medium of Lentinus edodes mycelia on the replication of herpes simplex virus type 1
    646. antiviral effect of theaflavins against calicivirus es
    647. antiviral effects and possible mechanisms of action of constituents from Brazilian propolis and related compounds
    648. antiviral effects of a Malaysia medicinal plant (Phyllanthus)
    649. antiviral effects of ABMA against herpes simplex virus type 2 in vitro and in vivo
    650. antiviral Effects of Baicalein on Human Cytomegalovirus in Vitro
    651. antiviral effects of baicalin combined with peramivir against pandemic 2009 H1N1 virus in vitro and in vivo
    652. antiviral effects of black raspberry (Rubus coreanus) seed and its gallic acid against influenza virus infection
    653. antiviral effects of blackberry extract against herpes simplex virus type 1
    654. antiviral effects of blueberry proanthocyanidin s against Aichi virus
    655. antiviral effects of Brazilian green and red propolis extract s on Enterovirus surrogates
    656. antiviral effects of grape seed extract against feline calicivirus , murine norovirus , and hepatitis A virus in model food systems and under gastric conditions
    657. antiviral effects of green tea (Camellia sinensis) against pathogenic virus es in human and animals (a mini-review)
    658. antiviral Effects of Houttuynia cordata Polysaccharide extract on Murine Norovirus -1 (MNV-1)—A Human Norovirus Surrogate
    659. antiviral Effects of Lactococcus lactis on Feline Calicivirus , A Human Norovirus Surrogate
    660. antiviral effects of Melia azedarach L. leaves extract s on Sindbis virus -infected cells
    661. antiviral effects of modified Dingchuan decoction against respiratory syncytial virus infection in vitro and in an immunosuppressive mouse model
    662. antiviral Effects of Mulberry (Morus alba) Juice and Its Fractions on Foodborne viral Surrogates
    663. antiviral effects of Nauclea latifolia on Newcastle disease virus (NDV)
    664. antiviral effects of novel herbal medicine KIOM-C, on diverse virus es
    665. antiviral effects of olea europaea leaves extract and interferon-beta on gene expression of newcastle disease virus
    666. antiviral effects of persimmon extract on human norovirus and its surrogate, bacteriophage MS2
    667. antiviral effects of plant -derived essential oils and pure oil components
    668. antiviral effects of POLYPHENOLS : Development of bio-based cleaning wipes and filters
    669. antiviral effects of saffron and its major ingredients
    670. antiviral effects of the constituents derived from Chinese herb medicines on infectious bursal disease virus
    671. antiviral effects on bacteriophages and rotavirus by cranberry juice
    672. antiviral efficacy against hepatitis B virus replication of oleuropein isolated from Jasminum officinale L. var. grandiflorum
    673. antiviral Efficacy of FLAVONOIDS against Enterovirus 71 Infection in Vitro and in Newborn Mice
    674. antiviral efficacy of Limonium densiflorum against HSV-1 and influenza virus es
    675. antiviral enantiomers of a bisindole alkaloid with a new carbon skeleton from the roots of Isatis indigotica
    676. antiviral evaluation of plant s from Brazilian atlantic tropical forest
    677. antiviral Flavans from the Leaves of Pithecellobium clypearia
    678. antiviral flavone s from the leaves of Nicotiana tabacum
    679. antiviral flavonoid from Pterocaulon sphacelatum, an Australian Aboriginal medicine
    680. antiviral Flavonoid‐Type C‐Glycosides from the Flowers of Trollius chinensis
    681. antiviral FLAVONOIDS from Alkanna orientalis
    682. antiviral FLAVONOIDS from Mosla scabra
    683. antiviral FLAVONOIDS from the root bark of Morus alba L.
    684. antiviral FLAVONOIDS from the Seeds of Aesculus chinensis
    685. antiviral glycosidic bisindole alkaloids from the roots of Isatis indigotica
    686. antiviral herbs-present and future
    687. antiviral In vitro activity of Hypericum perforatum l. extract on the human cytomegalovirus (HCMV)
    688. antiviral investigation on the FLAVONOIDS of Chamaesyce thymifolia
    689. antiviral isoflavonoid sulfate and steroidal glycosides
    690. antiviral Matrine-Type alkaloids from the Rhizomes of Sophora tonkinensis
    691. antiviral Mechanism of Action of Epigallocatechin-3-O-gallate and Its Fatty Acid Esters
    692. antiviral medication in sexually transmitted diseases. Part I: HSV, HPV
    693. antiviral medicinal plant s of Iran: A Review of Ethnobotanical evidence
    694. antiviral molecules of enterovirus es
    695. antiviral natural products against chronic hepatitis B: recent developments
    696. antiviral natural products and herbal medicines
    697. antiviral Oligo- and Polyribonucleotides Containing Selected Triazolo[2,3-a]purines
    698. antiviral Phenolic Compounds from Arundina gramnifolia
    699. antiviral phenolics from the leaves of Cleistocalyx operculatus
    700. antiviral phloroglucinols from New Zealand Kunzea species
    701. antiviral phytocompounds for drug development: a data mining studies
    702. antiviral phytocompounds target envelop protein to control Zika virus
    703. antiviral Potential and Molecular Insight into Neuraminidase Inhibiting Diarylheptanoids from Alpinia katsumadai
    704. antiviral potential of a novel compound CW-33 against enterovirus A71 via inhibition of viral 2A protease
    705. antiviral potential of aqueous extract s of some parts of Momordica balsamina plant against newcastle disease virus
    706. antiviral potential of Bulgarian medicinal plant s
    707. antiviral potential of green synthesized silver nanoparticles of Lampranthus coccineus and Malephora lutea
    708. antiviral potential of medicinal plant s against HIV, HSV, influenza, hepatitis, and coxsackievirus : A systematic review
    709. antiviral potential of natural compounds against influenza virus hemagglutinin
    710. antiviral potential of selected Indian medicinal (ayurvedic) plant s against herpes simplex virus 1 and 2
    711. antiviral potential of vegetables: can they be cost-effective agents for human disease?
    712. antiviral Potentials of Enantia chlorantha extract s on Yellow Fever virus Taiye R. Fasola1, Faderera A. Adeyemo1, Joseph A. Adeniji2 and Iheanyi O. Okonko3 …
    713. antiviral potentials of medicinal plant s
    714. antiviral profile of brown and red seaweed polysaccharides against Hepatitis C virus
    715. antiviral properties and interaction of novel chalcone derivatives containing a purine and benzenesulfonamide moiety
    716. antiviral properties from plant s of the Mediterranean flora
    717. antiviral properties of essential oils of Foeniculum vulgare and Pimpinella anisum L
    718. antiviral properties of garlic cloves juice compared with onion bulbs juice against potato virus Y (PVY)
    719. antiviral properties of isoborneol, a potent inhibitor of herpes simplex virus type 1
    720. antiviral Properties of Orthosiphon stamineus Aqueous extract in Herpes Simplex virus Type 1 Infected Cells
    721. antiviral properties of phytochemicals
    722. antiviral Properties of Prodelphinidin B-2 3′-O-Gallate from Green Tea Leaf
    723. antiviral Properties of Propolis
    724. antiviral properties of resveratrol against pseudorabies virus are associated with the inhibition of IκB kinase activation
    725. antiviral properties of the natural POLYPHENOLS delphinidin and epigallocatechin gallate against the flavivirus es West Nile virus , Zika virus , and dengue virus
    726. antiviral property and mechanisms of a sulphated polysaccharide from the brown alga Sargassum patens against Herpes simplex virus type 1
    727. antiviral prospective of Tinospora cordifolia on HSV-1
    728. antiviral screening of British Columbian medicinal plant s
    729. antiviral screening of forty-two Egyptian medicinal plant s
    730. antiviral sesquiterpenes from leaves of Nicotiana tabacum
    731. antiviral stereoisomers of 3, 5-bis (2-hydroxybut-3-en-1-yl)-1, 2, 4-thiadiazole from the roots of Isatis indigotica
    732. antiviral stilbene 1, 2-diamines prevent initiation of hepatitis C virus RNA replication at the outset of infection
    733. antiviral strategies against human coronavirus es
    734. antiviral susceptibility of Herpes simplex virus es and its clinical correlates: a single center’s experience
    735. antiviral susceptibility of penciclovir resistant mutants derived from herpes simplex virus type 1 in various cell lines
    736. antiviral therapy for hepatitis C
    737. antiviral therapy for influenza
    738. antiviral Triterpenes from the Twigs and Leaves of Lyonia ovalifolia
    739. antiviral -guided fractionation and isolation of phenolic compounds from Limonium densiflorum hydroalcoholic extract
    740. antiviral , antibacterial and cytotoxic activities of South African plant s containing cardiac glycosides
    741. antiviral , antibacterial and vitamin C-synergized radical-scavenging activity of Sasa senanensis Rehder extract
    742. antiviral , antibacterial, anti-inflammatory and antipyretic effects of Chaiju oral liquid [J]
    743. antiviral , antimicrobial and anti-inflammatory activities of Urera baccifera (L.) Gaudich
    744. antiviral , antioxidant and toxicological evaluation of mangrove associate from South East coast of India
    745. antiviral , antioxidant and toxicological evaluation of mangrove plant from South East coast of India
    746. antiviral , Cytotoxicity, Antioxidant and Chemical Constituents of Adansonia digitata Grown in Egypt
    747. antiviral , embryo toxic and cytotoxic activities of Astragalus membranaceus root extract s.
    748. antiviral s against Chikungunya virus : Is the Solution in Nature?
    749. Apigenin inhibits African swine fever virus infection in vitro
    750. Apigenin inhibits enterovirus 71 replication through suppressing viral IRES activity and modulating cellular JNK pathway
    751. Apigenin inhibits enterovirus -71 infection by disrupting viral RNA association with trans-acting factors
    752. Apigenin restricts FMDV infection and inhibits viral IRES driven translational activity
    753. Apolipoprotein B–dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin
    754. Apoptosis of lymphocytes and monocytes infected with influenza virus might be the mechanism of combating virus and causing secondary infection by influenza
    755. Apoptosis signaling in influenza virus propagation, innate host defense, and lung injury
    756. Apple Pomace, a By-Product from the Asturian Cider Industry, Inhibits Herpes Simplex virus Types 1 and 2 In Vitro Replication: Study of Its Mechanisms of Action
    757. Application of high‐speed counter‐current chromatography for the isolation of antiviral eremophilenolides from Ligularia atroviolacea
    758. Application of radiobiological techniques in studying antioxidant mechanisms: evaluation of their radioprotective, antioxidative and antiviral activities
    759. Application of traditional Chinese medical herbs in prevention and treatment of respiratory syncytial virus
    760. Applications of Artificial Intelligence and Machine Learning in viral Biology
    761. Approaches and strategies for the treatment of influenza virus infections
    762. Arachidonic acid metabolism to eicosanoids in herpes virus -infected rabbit cornea.
    763. Argonaute 2 and antiviral Silencing in plant s
    764. Aronia melanocarpa and its components demonstrate antiviral activity against influenza virus es
    765. Asia is the mine of natural antiviral products for public health
    766. Assessment of a flavone -polysaccharide based prescription for treating duck virus hepatitis
    767. Assessment of antiviral activity for Lamiaceae family members against RNA and DNA virus models using cell-culture: in vitro study
    768. Assessment of antiviral and Photodynamic Inactivation Activity of Different Compounds Against Hepatitis A virus
    769. Assessment of Drug Binding Potential of Pockets in the NS2B/NS3 Dengue virus Protein
    770. Assessment of human-to-human transmissibility of avian influenza A (H7N9) virus across 5 waves by analyzing clusters of case patients in mainland China, 2013 …
    771. Assessment of Multidrug-Resistant Organism and viral Pathogen Transmission From the Rooms of Hospitalized Patients to Healthcare Workers and the Hospital …
    772. Assessment of potency of PC-complexed Ocimum sanctum methanol extract in embryonated eggs against Influenza virus (H1N1)
    773. Assessment of the Effect of Baicalin on Duck virus Hepatitis
    774. Assessment of Traditional Chinese herbal Medicine plant extract s’ Potential to Inhibit Activity of Herpes Simplex virus Type 1
    775. Astragalus Membranaceus Treatment Protects Raw264. 7 Cells from Influenza virus by Regulating G1 Phase and the TLR3-Mediated Signaling Pathway
    776. Astragalus mongholicus (Fisch.) Bge improves peripheral Treg cell immunity imbalance in the children with viral myocarditis by reducing the levels of miR …
    777. Astragalus Root dry extract restores connexin43 expression by targeting miR-1 in viral myocarditis
    778. Atomic mapping of the interactions between the antiviral agent cyanovirin-N and oligomannosides by saturation-transfer difference NMR
    779. Attachment and Penetration of Acyclovir‐resistant Herpes Simplex virus are Inhibited by Melissa officinalis extract
    780. Aurantiamide acetate from baphicacanthus cusia root exhibits anti-inflammatory and anti-viral effects via inhibition of the NF-κB signaling pathway in Influenza A virus …
    781. Authenticating apple cider vinegar’s home remedy claims: antibacterial, antifungal, antiviral properties and cytotoxicity aspect
    782. Avocado (Persea americana) fruit extract (2 R, 4 R)-1, 2, 4-trihydroxyheptadec-16-yne inhibits dengue virus replication via upregulation of NF-κB–dependent …
    783. Ayapana triplinervis Essential Oil and Its Main Component Thymohydroquinone Dimethyl Ether Inhibit Zika virus at Doses Devoid of Toxicity in Zebrafish
    784. Baicalein and baicalin as Zika virus inhibitors
    785. Baicalin from Scutellaria baicalensis blocks respiratory syncytial virus (RSV) infection and reduces inflammatory cell infiltration and lung injury in mice
    786. Baicalin in flavocoxid may act against hepatitis B virus via a pro-inflammatory pathway
    787. Baicalin inhibits TLR7/MYD88 signaling pathway activation to suppress lung inflammation in mice infected with influenza A virus
    788. Baicalin is an inhibitor of subgroup J avian leukosis virus infection
    789. Baicalin, a metabolite of baicalein with antiviral activity against dengue virus
    790. Bay laurel (Laurus nobilis) as potential antiviral treatment in natural ly BQCV infected honeybees
    791. Bell palsy and herpes simplex virus
    792. Benzophenone C-glucosides and gallotannins from mango tree stem bark with broad-spectrum anti-viral activity
    793. Berberine inhibits hepatitis C virus entry by targeting the viral E2 glycoprotein
    794. Betulinic acid exerts anti‐hepatitis C virus activity via the suppression of NF‐κ B‐and MAPK‐ERK 1/2‐mediated COX‐2 expression
    795. Beyond the Biological Effect of a Chemically Characterized Poplar Propolis: Antibacterial and antiviral Activity and Comparison with Flurbiprofen in cytokine s Release …
    796. Bicyclic octahydrocyclohepta [b] pyrrol-4 (1H) one derivatives as novel selective anti-hepatitis C virus agents
    797. Biflavanone s, Flavonoids, and Coumarins from the Roots of Stellera chamaejasme and Their antiviral Effect on Hepatitis B virus
    798. Astragalus Membranaceus Treatment Protects Raw264. 7 Cells from Influenza virus by Regulating G1 Phase and the TLR3-Mediated Signaling Pathway
    799. Astragalus mongholicus (Fisch.) Bge improves peripheral Treg cell immunity imbalance in the children with viral myocarditis by reducing the levels of miR …
    800. Astragalus Root dry extract restores connexin43 expression by targeting miR-1 in viral myocarditis
    801. Atomic mapping of the interactions between the antiviral agent cyanovirin-N and oligomannosides by saturation-transfer difference NMR
    802. Attachment and Penetration of Acyclovir‐resistant Herpes Simplex virus are Inhibited by Melissa officinalis extract
    803. Aurantiamide acetate from baphicacanthus cusia root exhibits anti-inflammatory and anti-viral effects via inhibition of the NF-κB signaling pathway in Influenza A virus …
    804. Authenticating apple cider vinegar’s home remedy claims: antibacterial, antifungal, antiviral properties and cytotoxicity aspect
    805. Avocado (Persea americana) fruit extract (2 R, 4 R)-1, 2, 4-trihydroxyheptadec-16-yne inhibits dengue virus replication via upregulation of NF-κB–dependent …
    806. Ayapana triplinervis Essential Oil and Its Main Component Thymohydroquinone Dimethyl Ether Inhibit Zika virus at Doses Devoid of Toxicity in Zebrafish
    807. Baicalein and baicalin as Zika virus inhibitors
    808. Baicalin from Scutellaria baicalensis blocks respiratory syncytial virus (RSV) infection and reduces inflammatory cell infiltration and lung injury in mice
    809. Baicalin in flavocoxid may act against hepatitis B virus via a pro-inflammatory pathway
    810. Baicalin inhibits TLR7/MYD88 signaling pathway activation to suppress lung inflammation in mice infected with influenza A virus
    811. Baicalin is an inhibitor of subgroup J avian leukosis virus infection
    812. Baicalin, a metabolite of baicalein with antiviral activity against dengue virus
    813. Bay laurel (Laurus nobilis) as potential antiviral treatment in natural ly BQCV infected honeybees
    814. Bell palsy and herpes simplex virus
    815. Benzophenone C-glucosides and gallotannins from mango tree stem bark with broad-spectrum anti-viral activity
    816. Berberine inhibits hepatitis C virus entry by targeting the viral E2 glycoprotein
    817. Bioactive compounds screening from Zingiberaceae family as influenza a/swine flu virus neuraminidase inhibitor through docking approach
    818. Bioactive constituents of Lindernia crustacea and its anti-EBV effect via Rta expression inhibition in the viral lytic cycle
    819. Bioactive natural products with anti‐herpes simplex virus properties
    820. Bioactivity-guided fractionation and analysis of compounds with anti-influenza virus activity from Gardenia jasminoides ellis
    821. Bioactivity-guided isolation of anti-hepatitis B virus active sesquiterpenoids from the traditional Chinese medicine: Rhizomes of Cyperus rotundus
    822. Bioassay-guided isolation of anti-hepatitis B virus flavonoid myricetin-3-O-rhamnoside along with quercetin from Guiera senegalensis leaves
    823. Biocomputational approaches towards deciphering anti-dengue viral properties of synthetic and natural moieties
    824. Bioguided isolation of an antiviral compound from Xylophragma myrianthum (Cham.) Sprague (Bignoniaceae Juss.)
    825. BioHealthBase: informatics support in the elucidation of influenza virus host–pathogen interactions and virulence
    826. Biological assessment (antiviral and antioxidant) and acute toxicity of essential oils from Drimys angustifolia and D. brasiliensis
    827. Biological characteristics of dengue virus and potential targets for drug design
    828. Biomarkers for virus -induced hepatocellular carcinoma (HCC)
    829. Biophysical and flavonoid-binding studies of the G protein ectodomain of group A human respiratory syncytial virus
    830. Bioprospecting of Red Sea Sponges for Novel antiviral Pharmacophores
    831. Block of vesicular stomatitis virus endocytic and exocytic pathways by 1-cinnamoyl-3, 11-dihydroxymeliacarpin, a tetranortriterpenoid of natural origin
    832. Blocking HCV entry as potential antiviral therapy
    833. Boerhaavia diffusa-Derived antiviral Glycoprotein: A Novel, Eco-friendly Approach for the Management of viral Diseases
    834. Breaking Down the Barriers to a natural antiviral Agent: antiviral Activity and Molecular Docking of Erythrina speciosa extract , Fractions, and the Major Compound
    835. Brief Report: Disseminated Mycobacteriosis Caused by Drug-Resistant Mycobacterium triplex in a Human immunodeficiency virus -Infected Patient during Highly …
    836. Broad-spectrum antiviral properties of andrographolide
    837. Broad‐spectrum antiviral effect of Agrimonia pilosa extract on influenza virus es
    838. Budget Impact Analysis of Oral antiviral Agents for the Treatment of Chronic Hepatitis B in South Korea
    839. Bystander effect mediated by herpes simplex virus -thymidine kinase/ganciclovir approach on prostatic cancer cells and its regulation
    840. C-Methylated Flavonoid Glycosides from Pentarhizidium orientale Rhizomes and Their Inhibitory Effects on the H1N1 Influenza virus
    841. c‐Jun mediates hepatitis C virus hepatocarcinogenesis through signal transducer and activator of transcription 3 and nitric oxide–dependent impairment of oxidative …
    842. CAM/Drug-Induced Hepatotoxicity: Implications in viral Hepatitis
    843. Can ethnopharmacology contribute to the development of antiviral drugs?
    844. Cancer chemopreventive activity of Achyranthes aspera leaves on Epstein–Barr virus activation and two-stage mouse skin carcinogenesis
    845. Cancer chemopreventive activity of flavanone s on Epstein–Barr virus activation and two-stage mouse skin carcinogenesis
    846. Cancer chemopreventive effect of quassinoid derivatives. Introduction of side chain to shinjulactone C for enhancement of inhibitory effect on Epstein–Barr virus …
    847. Carnosine markedly ameliorates H9N2 swine influenza virus -induced acute lung injury
    848. Case-case comparison of smoking and alcohol risk associations with Epstein-Barr virus -positive gastric cancer.
    849. CD 38 modulates respiratory syncytial virus ‐driven proinflammatory processes in human monocyte‐derived dendritic cells
    850. CD46, a primate-specific receptor for measles virus
    851. Cellular models for the screening and development of anti-hepatitis C virus agents
    852. Changes in the Hemagglutinin and Neuraminidase Genes of Avian H9N2 Influenza virus Adapted in Embryonated Chicken Eggs
    853. Changes in viral load in different organs of Japanese Encephalitis virus ‑infected chick embryo under the influence of Belladonna 200C
    854. Changes of SOD activity and MDA level in young ducks infected with new type duck hepatitis virus [J]
    855. Changes of the Activities of SOD, CAT and GSH Px and the Level of MDA in Chicks Infected with Virulent Marek’s Disease virus [J]
    856. Characteristcs of Pathogen-specific Memory T cells in the Liver during acute viral infection
    857. Characterization and mechanisms of anti-influenza virus metabolites isolated from the Vietnamese medicinal plant Polygonum chinense
    858. Characterization of a novel human-specific STING agonist that elicits antiviral activity against emerging alphavirus es
    859. Characterization of alginic acid extract ed from sargassum wightii and determination of its antiviral activity on shrimp penaeus monodon postlarvae against white …
    860. Characterization of anti‐Coxsackie virus B3 constituents of Radix Astragali by high‐performance liquid chromatography coupled with electrospray ionization tandem …
    861. Characterization of Whey Protein Isolate Covalently Modified with Phenolic Compounds 1: Antioxidant and antiviral Activities
    862. Chemical components from the twigs of Caesalpinia latisiliqua and their antiviral activity
    863. Chemical composition and anti-herpes simplex virus type 1 (HSV-1) activity of extract s from Cornus canadensis
    864. Chemical Composition and antiviral Activity of Essential Oils from Citrus reshni hort. ex Tanaka (Cleopatra mandarin) Cultivated in Egypt
    865. Chemical Composition and antiviral Effect of extract s of Origanum vulgare
    866. Chemical composition of Propolis extract ACF® and activity against herpes simplex virus
    867. Chemical composition, antiviral against avian influenza (H5N1) virus and antimicrobial activities of the essential oils of the leaves and fruits of Fortunella …
    868. Chemical compositions, antiviral and antioxidant activities of seven essential oils
    869. Chemical Constituents and Anti-influenza viral Activity of the Leaves of Vietnamese plant Elaeocarpus tonkinensis.
    870. Chemical constituents and antiviral activity of Polygala fallax [J]
    871. Chemical constituents and antiviral study of Goniothalamus velutinus
    872. Chemical constituents from Chirita longgangensis var. hongyao with inhibitory activity against porcine respiratory and reproductive syndrome virus
    873. Chemical constituents from Lobelia chinensis and their anti-virus and anti-inflammatory bioactivities
    874. Chemical constituents from Melicope pteleifolia leaves and their anti-influenza virus activities
    875. Chemical constituents of Swertia yunnanensis and their anti-hepatitis B virus activity
    876. Chemical studies on constituents of some antiviral plant extract s
    877. Chemically-coupled-peptide-promoted virus nanoparticle templated mineralization
    878. Chemopreventive effect of resveratrol, sesamol, sesame oil and sunflower oil in the Epstein–Barr virus early antigen activation assay and the mouse skin two-stage …
    879. Chemotherapy: antiviral agents come of age
    880. Chikungunya virus (CHIKV) inhibitors from natural sources: a medicinal chemistry perspective
    881. Chikungunya virus drug discovery: still a long way to go?
    882. Chinese herbal medicine for carriers of the hepatitis B virus : an updated systematic review and meta-analysis
    883. Chromatographic Methods for Metabolite Profiling of virus – and Phytoplasma-Infected plant s of Echinacea purpurea
    884. chronic viral infection in the anti‐tumour necrosis factor therapy era in inflammatory bowel disease
    885. Cirsimaritin inhibits influenza A virus replication by downregulating the NF-κB signal transduction pathway
    886. Cissampelos sympodialis has anti-viral effect inhibiting dengue non-structural viral protein-1 and pro-inflammatory mediators
    887. Cladogynos orientalis Zipp. extract s inhibit cell culture-derived hepatitis C virus genotype 2a replication in Huh-7 cells through NS5B inhibition
    888. Clematis montana lectin, a novel mannose-binding lectin from traditional Chinese medicine with antiviral and apoptosis-inducing activities
    889. Clinical efficacy of L-carnitine in treating acute virus myocarditis
    890. Clinical Efficacy of SNMC in the Treatment Hepatic Fibrosis with Hepatitis B virus
    891. Clinical Observation of Chronic viral Hepatitis B Treated by Baicalin Capsules Combined with Adefovir Dipivoxil Tablets
    892. Clinical Observation of Compound Artemisiae Rupestris Granules Plus Other Traditional Chinese and Western Medicines in Treatment of viral Myocarditis
    893. Clinical Observation on Compound Glycyrrhizin Injection Combined with Alprostadil Injection for Severe Cholestatic virus Hepatitis [J]
    894. Clinical Observation on Pudilan Anti-inflammatory Oral Liquid for Treating viral Keratitis
    895. Clinical Research of Treating viral Infection of Upper Respiratory Tract in Children with Interferon Alpha 1b Atomized Inspiring [J]
    896. Clinical research on Shennong Gankang mixture curing viral hepatitis hyperbilirubinemia
    897. Clinoco-epidemic features of patients with chronic hepatitis C considering virus genotype in the Samara region
    898. Cloning and prokaryotic expression of binding protein 4 spliced variant HBeBP4A of hepatitis B virus e antigen
    899. Cloning and Sequencing of HA Gene of Avian Influenza virus Strain A/Font Monmouth/47 (H1N1)
    900. Coinfection with Epstein–barr virus (EBV), Human Papilloma virus (HPV) and Polyoma BK virus (BKPyV) in laryngeal, oropharyngeal and oral cavity cancer
    901. Combined action of antiviral substances of natural and synthetic origin. I. The anti-influenza action of a combination of the polyphenol complex isolated from Geranium …
    902. Combined Anti-influenza virus Effect of Synthetic and natural viral Inhibitors
    903. Combined antiinfluenza virus activity of Flos verbasci infusion and amantadine derivatives
    904. Combined antiinfluenza virus effect of a plant preparation and a bacterial protease inhibitor
    905. Combined antiviral effects of FLAVONOIDS and 5-ethyl-2′-deoxyuridine on the multiplication of herpesvirus es.
    906. Combined effect of selected antiviral substances of natural and synthetic origin. II. Anti-influenza activity of a combination of a polyphenolic complex isolated from …
    907. Combined therapy and precaution for viral myocarditis
    908. Combining Protein Interactions and Functionality Classification in NS3 to Determine Specific antiviral Targets in Dengue
    909. Commentary: The antiviral and antimicrobial activities of licorice, a widely-used Chinese herb
    910. Comparative analysis of cytokine s in children with chronic virus hepatitis В and C
    911. Comparative anti-infectious bronchitis virus (IBV) activity of (-)-pinene: effect on nucleocapsid (N) protein
    912. Comparative Antioxidant Study of Stem and Stem Induced Callus of Phyllanthus fraternus Webster—An Important antiviral and Hepatoprotective plant
    913. Comparative antiviral Activities of Diospyros Mespiliformis and Quisqualis indica Leaf extract s on Newcastle Disease.
    914. Comparative characteristic of clinical features of replicative and integrative phases of chronic virus hepatites B in children and teenagers
    915. Comparative evaluation of in-vitro cytotoxicity, antiviral and antioxidant activities of different soyasapogenols from soybean saponin
    916. Comparative proteomics reveals that YK51, a 4-Hydroxypandurantin-A analogue, downregulates the expression of proteins associated with dengue virus …
    917. Comparative Study on In Vitro Activities of Citral, Limonene and Essential Oils from Lippia citriodora and L. alba on Yellow Fever virus
    918. Comparative Study on the Main Herbs of Lonicerae and Forsythiae Powder Inhibiting Influenza virus in Vitro [J]
    919. Comparison between in vitro antiviral effect of Mexican propolis and three commercial FLAVONOIDS against canine distemper virus
    920. Comparison between In Vitro antiviral Effect of Mexican Propolis and Three Commercial FLAVONOIDS against Canine Distemper virus
    921. Comparison of in vitro antiviral activity of tea POLYPHENOLS against influenza A and B virus es and structure–activity relationship analysis
    922. Comparison of the anti-herpes simplex virus activities of propolis and 3-methyl-but-2-enyl caffeate
    923. Comparison of the antiviral activity of FLAVONOIDS against murine norovirus and feline calicivirus
    924. Comparison of the effects of glycyrrhiza and glycyrrhiza acid on the anti-respiratory syncytial virus in vitro [J]
    925. Complex compounds of zinc and copper(ii) ions with dihydroquercetin and their antiviral activity
    926. Complex formation of quercetin with lanthanum enhances binding to plant viral satellite double stranded RNA
    927. Compounds from rose (Rosa rugosa) flowers with human immunodeficiency virus type 1 reverse transcriptase inhibitory activity
    928. Comprehensive analysis of the effects of ordinary nutrients on hepatitis C virus RNA replication in cell culture
    929. Comprehensive characterisation of POLYPHENOLS in leaves and stems of three anti‐dengue virus type‐2 active Brazilian Faramea species (Rubiaceae) by HPLC‐DAD …
    930. Computational breakthrough of natural lead hits from the genus of Arisaema against human respiratory syncytial virus
    931. Computational Drug Design against Ebola virus Targeting viral Matrix Protein VP30
    932. Computational exploration of antiviral activity of phytochemicals against NS2B/NS3 proteases from dengue virus
    933. Computational insight into flavonoid-based compound for inhibition activity on SAH-binding site of dengue virus NS5 methyltransferase: Molecular docking and in …
    934. Computational methods for de novo protein design and its applications to the human immunodeficiency virus 1, purine nucleoside phosphorylase, ubiquitin specific …
    935. Computational screening of known broad-spectrum antiviral small organic molecules for potential influenza HA stem inhibitors
    936. Computational screening of medicinal plant phytochemicals to discover potent pan-serotype inhibitors against dengue virus
    937. Computational Simulation of Studying Zika virus : from Macroscale to Nanoscale
    938. Computational study on new natural polycyclic compounds of H1N1 influenza virus neuraminidase
    939. Computer-aided analysis of phytochemicals as potential dengue virus inhibitors based on molecular docking, ADMET and DFT studies
    940. Computer-aided docking studies of phytochemicals from plant s Salix subserrata and Onion as inhibitors of glycoprotein G of rabies virus
    941. Computer-Aided Drug Design for NS5 Protein of Zika virus
    942. Computer-aided drug design of broad-spectrum antiviral compounds
    943. Concurrent juvenile cellulitis and metaphyseal osteopathy: an atypical canine distemper virus syndrome?
    944. Confirmation of the antiviral properties of medicinal plant s via chemical analysis, machine learning methods and antiviral tests: a methodological approach
    945. Conjugated bilirubin increases T regulatory cell suppressor function during hepatitis A virus infection through a T cell immunoglobulin and mucin domain …
    946. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes
    947. Construction and biological properties of yellow fever 17D/dengue type 1 recombinant virus
    948. Constructions of hepatitis C virus prophylactic vaccine candidate using Berberis vulgaris stimulated and nonstructural protein 3 loaded dendritic cells
    949. Contribution of autophagy to antiviral immunity
    950. Conversion of quassinoids for enhancement of inhibitory effect against Epstein-Barr virus early antigen activation. Introduction of lipophilic side chain and esterification …
    951. Correlation between oxidation potentials and inhibitory effects on Epstein–Barr virus activation of flavonoids
    952. Correlation with redox potentials and inhibitory effects on Epstein-Barr virus activation of azaanthraquinones
    953. Cost-effectiveness analysis of zedoary turmeric oil and ribavirin in treatment of viral pneumonia of children
    954. Cucurbitacin B interacts synergistically with antibiotics against Staphylococcus aureus clinical isolates and exhibits antiviral activity against HSV-1
    955. Curcumin against hepatitis C virus infection: spicing up antiviral therapies with ‘nutraceuticals’?
    956. Curcumin shows antiviral properties against norovirus
    957. Current and future anti-influenza virus drugs
    958. Current and future targets of antiviral therapy in the hepatitis C virus life cycle
    959. Current breakthroughs in structure-based design of synthetic and natural sourced inhibitors against zika viral targets
    960. Current landscape and future prospects of antiviral drugs derived from microbial products
    961. Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection
    962. Current status of natural products from plant s as anti-herpes simplex virus 1 agents
    963. Cyclin-dependent kinases as cellular targets for antiviral drugs
    964. Cyclosporine A inhibits hepatitis C virus nonstructural protein 2 through cyclophilin A
    965. CYSTUS052, a polyphenol-rich plant extract , exerts anti-influenza virus activity in mice
    966. CYTOTOXIC AND ANTI-viral ACTIVITY OF Acacia catechu ON HUMAN PERIPHERAL BLOOD MONONUCLEAR CELLS
    967. Cytotoxic and antiviral compounds from bryophytes and inedible fungi
    968. Cytotoxic and antiviral potentials of Euphorbia milii var. splendens leaf against Peste des petits ruminant virus
    969. Cytotoxic and antiviral triterpenoids from the mangrove plant Sonneratia paracaseolaris
    970. Cytotoxic effect (on tumor cells) and in vitro antiviral activity against herpes simplex virus of synthetic spongiane diterpenes
    971. Cytotoxic, antimicrobial and antiviral secondary metabolites produced by the plant pathogenic fungus Cytospora sp. CCTU A309
    972. Cytotoxicity and antiviral activities of Asplenium nidus, Phaleria macrocarpa and Eleusine indica
    973. Cytotoxicity and antiviral activity evaluation of Cymbopogon spp hydroethanolic extract s
    974. Cytotoxicity and antiviral activity of Annona muricata aqueous leaves extract against dengue virus type 2
    975. Cytotoxicity and antiviral activity of methanol extract from Polygonum minus
    976. Cytotoxicity and potential antiviral evaluation of violacein produced by Chromobacterium violaceum
    977. Cytotoxicity, antiviral and antimicrobial activities of alkaloids , flavonoids, and phenolic acids
    978. Daphne Genkwa sieb. Et zucc. Water-soluble extract s act on enterovirus 71 by inhibiting viral entry
    979. Deciphering the potential of baicalin as an antiviral agent for Chikungunya virus infection
    980. Decrease in Dengue virus -2 infection and reduction of cytokine /chemokine production by Uncaria guianensis in human hepatocyte cell line Huh-7
    981. Delivery of Vaccinia virus Complement Control Protein (VCP) and Curcumin to the rodents’ brain: implications in Alzheimer’s disease and HIV dementia
    982. Dengue antiviral activity of polar extract from Melochia umbellata (Houtt) Stapf var. Visenia
    983. Dengue virus Disease: Current Updates on the use of Carica Papaya Leaf extract as a Potential herbal Medicine
    984. Dengue virus immunopathogenesis: Lessons applicable to the emergence of Zika virus
    985. Dengue virus infections and anti-dengue virus activities of Andrographis paniculata
    986. Dengue virus Inhibition Targets: A Review and Docking Study
    987. Design and evaluation of substrate-based octapeptide and non substrate-based tetrapeptide inhibitors of dengue virus NS2B–NS3 proteases
    988. Design and Synthesis of Various 6′-Modified Novel Nucleoside Analogues as Potent antiviral Agents
    989. Design, synthesis, and anti-influenza viral activities of 1, 3-diarylprop-2-en-1-ones: a novel class of neuraminidase inhibitors
    990. Design, Synthesis, antiviral Activities of Novel Phosphonate Derivatives Containing Quinazoline Based on Chalone Motif
    991. Designer Polymers for Non-viral Gene Transfection
    992. Designing and screening of universal drug from neem (Azadirachta indica) and standard drug chemicals against influenza virus nucleoprotein
    993. Designing antiviral Substances Targeting the Ebola virus viral Protein 24
    994. Designing Ecofriendly Bionanocomposite Assembly with Improved Antimicrobial and Potent on-site Zika virus Vector Larvicidal Activities with its Mode of …
    995. Detection of a Vero Cell-adapted H3N2 Influenza virus Strain by ELISA Method
    996. Detection of amphipathic viral peptide on screen-printed electrodes by liposome rupture impact voltammetry
    997. Detection of the antiviral activity of epicatechin isolated from Salacia crassifolia (Celastraceae) against Mayaro virus based on protein C homology modelling and …
    998. DETERMINATION OF ANTI-RABIES virus ACTIVITIES OF CRUDE extract S FROM SOME TRADITIONALLY USED MEDICINAL plant S IN EAST WOLLEGA …
    999. Determination of antioxidant activity, phenolic contents and antiviral potential of methanol extract of Euphorbia spinidens Bornm (Euphorbiaceae)
    1000. Determination of antiviral Activities of Quisqualis indica leaf extract s on Three Selected Avian virus es
    1001. Determination of antiviral activity and cytotoxicity of selected sage (Salvia L.) species
    1002. Determination of the content of flavonoid in the active fraction against influenza virus of Yinqiao powder
    1003. Determine the structure of phosphorylated modification of icariin and its antiviral activity against duck hepatitis virus A
    1004. Development of a Cell-Based Hepatitis C virus (HCV) Infection FRET Assay for High Throughput antiviral Compound Screening
    1005. Development of a cell-based hepatitis C virus infection fluorescent resonance energy transfer assay for high-throughput antiviral compound screening
    1006. Development of a theoretical model for the inhibition of nsP3 protease of Chikungunya virus using pyranooxazoles
    1007. Development of a virus -induced gene silencing (VIGS) system for Spinacia oleracea L.
    1008. Development of Anti-viral Agents from natural Sources
    1009. Development of anti-viral agents using molecular modeling and virtual screening techniques
    1010. Development of antiviral therapy for severe acute respiratory syndrome
    1011. Development of chemical inhibitors of the SARS coronavirus : viral helicase as a potential target
    1012. Development of neuraminidase inhibitors as anti‐influenza virus drugs
    1013. Development of Oligonucleotide Therapeutics as antiviral Agents
    1014. Development of Small-Molecule Inhibitors Against Zika virus Infection
    1015. Develpment of Novel Carbocyclic Nucleosides as Potent antiviral and Antitumor Agents
    1016. Dietary FLAVONOIDS and modulation of natural killer cells: implications in malignant and viral diseases
    1017. Different inhibitory potencies of oseltamivir carboxylate, zanamivir, and several tannins on bacterial and viral neuraminidases as assessed in a cell-free fluorescence …
    1018. Differential alterations of glutathione S-transferase enzyme activities in three sorghum varieties following viral infection
    1019. Differential antiviral and anti-inflammatory mechanisms of the FLAVONOIDS biochanin A and baicalein in H5N1 influenza A virus -infected cells
    1020. Differential inhibitory effects of some catechin derivatives on the activities of human immunodeficiency virus reverse transcriptase and cellular deoxyribonucleic and …
    1021. Digallate dimers of (−)-epigallocatechin gallate inactivate herpes simplex virus
    1022. Dimeric Matrine-Type alkaloids from the Roots of Sophora flavescens and Their Anti-Hepatitis B virus Activities
    1023. Dioscin’s antiviral effect in vitro
    1024. Dioxin-induced deregulation of neutrophil recruitment to the lungs of mice infected with influenza virus
    1025. Direct virucidal action against influenza virus of an extract of Punica granatum L (granada)
    1026. Discordant Activity of Kaempferol Towards Dengue virus and Japanese Encephalitis virus
    1027. Discovery and characterization of diazenylaryl sulfonic acids as inhibitors of viral and bacterial neuraminidases
    1028. Discovery of a new sesquiterpenoid from Phellinus ignarius with antiviral activity against influenza virus
    1029. Discovery of a series of novel compounds with moderate anti-avian H5N1 influenza virus activity in chick embryo
    1030. Discovery of antiviral molecules for dengue: In silico search and biological evaluation
    1031. Discovery of Dengue virus Inhibitors
    1032. Discovery of natural ly occurring aurones that are potent allosteric inhibitors of hepatitis C virus RNA-dependent RNA polymerase
    1033. Discovery of novel natural FLAVONOIDS as potent antiviral candidates against hepatitis C virus NS5B polymerase
    1034. Discovery of novel small molecule inhibitors of dengue viral NS2B-NS3 protease using virtual screening and scaffold hopping
    1035. Discovery of potent non-nucleoside inhibitors of dengue viral RNA-dependent RNA polymerase from a fragment hit using structure-based drug design
    1036. Discovery of prenylated FLAVONOIDS with dual activity against influenza virus and Streptococcus pneumoniae
    1037. Discovery of small molecule inhibitors of chikungunya virus proteins (nsP2 and E1) using in silico approaches
    1038. Discovery of the antiviral activities of pharmacologic cyclin-dependent kinase inhibitors: from basic to applied science
    1039. Discussion about traditional Chinese medicine anti-hepatitis B virus and its research ideas
    1040. Discussion on pathogenesis of viral myocarditis based on theory of the spleen and stomach [J]
    1041. Disruption of virus -host cell interactions and cell signaling pathways as an anti-viral approach against influenza virus infections
    1042. Distinct molecular signatures in dissolved organic matter produced by viral lysis of marine cyanobacteria
    1043. Divergent antiviral effects of bioFLAVONOIDS on the hepatitis C virus life cycle
    1044. Diversity of pharmacological properties in Chinese and European medicinal plant s: cytotoxicity, antiviral and antitrypanosomal screening of 82 herbal drugs
    1045. DMO-CAP inhibits influenza virus replication by activating heme oxygenase-1-mediated IFN response
    1046. DNA related enzymes as molecular targets for antiviral and antitumoral chemotherapy. A natural overview of the current perspectives
    1047. DNMT1 mediates metabolic reprogramming induced by Epstein–Barr virus latent membrane protein 1 and reversed by grifolin in nasopharyngeal carcinoma
    1048. Docking of noncompetitive inhibitors into dengue virus type 2 protease: understanding the interactions with allosteric binding sites
    1049. Docking of Phytoconstituents of Cynodon dactylon on NS2B NS3 protease domain of Dengue virus
    1050. Docking studies of Pakistani HCV NS3 helicase: a possible antiviral drug target
    1051. Docking study of flavonoid derivatives as potent inhibitors of influenza H1N1 virus neuraminidase
    1052. Does an apple a day keep the doctor away because a phytoestrogen a day keeps the virus at bay? A review of the anti-viral properties of phytoestrogens
    1053. Does hepatitis B virus infection cause breast cancer
    1054. Domain dissection of large polyproteins as a tool for structure-function studies: Examples from bacterial polyketide synthases and viral replicases
    1055. Doratoxylon apetalum, an indigenous medicinal plant from Mascarene Islands, is a potent inhibitor of Zika and dengue virus infection in human cells
    1056. Down-regulation of flavonoid 3′-hydroxylase gene expression by virus -induced gene silencing in soybean reveals the presence of a threshold mRNA level …
    1057. Drosophila as a model for antiviral immunity
    1058. Drug resistance of human immunodeficiency virus and overcoming it by natural products
    1059. Drug targets for corona virus : A systematic review.
    1060. Drug–drug interactions during antiviral therapy for chronic hepatitis C
    1061. Early evolution of hepatitis C virus (HCV) quasispecies after liver transplant for HCV-related disease
    1062. Ebola viral protein 24 (VP24) inhibitor discovery by In silico fragment-based design
    1063. Ebselen alleviates testicular pathology in mice with Zika virus infection and prevents its sexual transmission
    1064. EBV-associated cancers: Strategies for targeting the virus
    1065. Ecological mechanisms that promote arbovirus survival: a mathematical model of Ross River virus transmission
    1066. Ectromelia virus upregulates the expression of heat shock protein 70 to promote viral replication
    1067. Effect of a water-soluble derivative of silymarin on morphological and functional alterations of mouse hepatocytes induced by Frog virus 3 (author’s transl)
    1068. Effect of ampelopsis of ampelopsis grossedentata on duck hepatitis B virus
    1069. Effect of antiviral substances on hepatitis A virus replication in vitro
    1070. Effect of antiviral treatment on the outcome of secondary bacterial pneumonia after influenza
    1071. Effect of Argemone mexicana active principles on inhibiting viral multiplication and stimulating immune system in Pacific white leg shrimp Litopenaeus vannamei …
    1072. Effect of artemisinin/artesunate as inhibitors of hepatitis B virus production in an “in vitro” replicative system
    1073. Effect of baicalin on in vivo anti-virus
    1074. Effect of cacao husk extract on human immunodeficiency virus infection
    1075. Effect of Dietary Soy Genistein on Pig Growth and immune Response during a viral Challenge
    1076. Effect of Egyptian propolis on the susceptibility of LDL to oxidative modification and its antiviral activity with special emphasis on chemical composition
    1077. Effect of freeze-dried Carica papaya leaf juice on inflammatory cytokine s production during dengue virus infection in AG129 mice
    1078. Effect of hemagglutinin glycosylation on influenza virus susceptibility to neuraminidase inhibitors
    1079. Effect of Hippophae rhamnoides leaf extract against Dengue virus infection in human blood-derived macrophages
    1080. Effect of Honeysuckble Compound Preparation on Proliferation of Lymphocytes in immune Organs of Chickens Infected with Newcastle Disease virus
    1081. Effect of Huang Jin Fang in the prevention and treatment of influenza A H_1N_1 virus in mice [J]
    1082. Effect of Huang Jin Fang on influenza virus load and immunity in mice
    1083. Effect of Infectious Bursal Disease virus on Oxidation-antioxidution Ability of Chickens
    1084. Effect of interferon-α2b therapy on St. Louis viral meningoencephalitis: clinical and laboratory results of a pilot study
    1085. Effect of interleukin-18 combined with high-dose vitamin C on viral myocarditis [J]
    1086. Effect of Korean arbor vitae (Thuja koraiensis) extract on antimicrobial and antiviral activity
    1087. Effect of modified amantadine on immune function of mice infected with influenza A (H5N1) virus
    1088. Effect of Moringa oleifera feed supplementation on the serum biochemical profile of broilers challenged with very virulent infectious bursal disease virus
    1089. Effect of naringenin, hesperetin and their glycosides forms on the replication of the 17D strain of yellow fever virus
    1090. Effect of nuclear polyhedrosis virus infection on the activity of carboxylesterase and glutathione s-transferase in Helicoverpa armigera (Hbn)
    1091. Effect of Oenanthe javanica flavone on human and duck hepatitis B virus infection1
    1092. Effect of p-fluorophenylalanine on the multiplication of foot-and-mouth disease virus
    1093. EFFECT OF PHYTONUTRIENT ‘VITASTIM’ON CHICKEN MUCOSAL IMMUNITY AGAINST LOW PATHOGENIC AVIAN INFLUENZA virus H4N6
    1094. Effect of Pinus massoniana Lamb. bark extract on lytic cycle of Epstein-Barr virus
    1095. Effect of propolis extract on malignant cell transformation by moloney murine sarcoma virus
    1096. Effect of quercetin on hepatitis C virus life cycle: from viral to host targets
    1097. Effect of Quercetin on lipid peroxidation and changes in lung morphology in experimental influenza virus infection
    1098. Effect of quercetin on the course of mengo virus infection in immunodeficient and normal mice. A histologic study.
    1099. Effect of quercetin supplementation on lung antioxidants after experimental influenza virus infection
    1100. Effect of root extract from Boerhaavia diffusa L., containing an antiviral principle upon plaque formation of RNA bacteriophages
    1101. Effect of Sheng Mai San on the Symptoms and the Markers of Inflammatory Damage in Patients with Acute viral Myocarditis
    1102. Effect of Silybin on Coxsackie B_5 virus Infected New Born Rat Heart Cells in Culture [J]
    1103. Effect of Skullcap Bupleurum Chinense and Compatibility extract on Expression of CVB3m-RNA and IFN mRNA in the Myocardium in Mice with viral Myocarditis [J]
    1104. Effect of some neem products on transmission of cotton leaf curl virus through Bemisia tabaci.
    1105. Effect of tannic acid on the development and resistance of the gypsy moth Lymantria dispar L. to viral infection
    1106. Effect of the antiviral compound MDL 20,610 on some aspects of murine immune function
    1107. Effect of the Water extract from Helicteres angustifolia on Activity of SOD and Contents of NO, LPO in Duck Model for Chronic Hepatitis B virus Infection
    1108. Effect of total FLAVONOIDS of Scutellaria baicalensis Georgi on expression of influenza A virus nucleoprotein in HeLa cells
    1109. Effect of treatment with certain FLAVONOIDS on Mengo virus -induced encephalitis in mice
    1110. Effect of ultrasound technology combined with binary mixtures of ethanol and water on antibacterial and antiviral activities of Erodium glaucophyllum extract s
    1111. Effect of viola yedoensis makino on hepatitis B virus detected by laser confocal scanning microscopy
    1112. Effect of vitamin A on tumor development in burned, unburned, and glucocorticoid-treated mice inoculated with an oncogenic virus
    1113. Effect of Yin-Qiao-Jie-Du Pill on β-defensin1’s Expression in Lung Tissue of Mice Infected With Influenza A virus [J]
    1114. Effect of Yixinkang soup on cardiocytes of suckling rats infected by CVB_3 virus [J]
    1115. Effect on non-steroidal anti-inflammatory drugs on Moloney sarcoma virus inoculated mice
    1116. Effective antiviral medicinal plant s and biological compounds against central nervous system infections: A mechanistic review.
    1117. Effective Component Selection of Atraotydin extract against Influenza virus [J]
    1118. Effectiveness of alternative treatments for reducing potential viral contaminants from plasma-derived products
    1119. Effectiveness of periodic treatment of quercetin against influenza A virus H1N1 through modulation of protein expression
    1120. Effects analysis of antiherpes simplex virus type-1 with combination of Rhizoma polygoni cusp idati and Lonicerahypoglauca Miq [J]
    1121. Effects and tolerance of silymarin (milk thistle) in chronic hepatitis C virus infection patients: a meta-analysis of randomized controlled trials
    1122. Effects of baicalein on Sendai virus in vivo are linked to serum baicalin and its inhibition of hemagglutinin-neuraminidase
    1123. Effects of Clinacanthus siamensis leaf extract on influenza virus infection
    1124. Effects of dietary soy isoflavone s and soy protein source on response of weanling pigs to porcine reproductive and respiratory syndrome viral infection
    1125. Effects of different principles of traditional Chinese medicine treatment on TLR7/NF-κB signaling pathway in influenza virus infected mice
    1126. Effects of Esberitox N on viral Titer of Salivary Gland in Cytomegalovirus -Infected Mice [J]
    1127. Effects of flavonoid-induced oxidative stress on anti-H5N1 influenza a virus activity exerted by baicalein and biochanin A
    1128. Effects of Gryllus bimaculatus (Gb) fractions on viral hepatitis
    1129. Effects of Hepatitis B virus X protein on the expression of interferon-induced MxA protein [J]
    1130. Effects of hop water extract s on hemagglutination reaction of influenza A virus and influenza A virus -induced mortality in mice
    1131. Effects of Ilex paraguariensis A. St. Hil. (Yerba Mate) on Herpes Simplex virus Types 1 and 2 Replication
    1132. Effects of interferon and Astragalus membranaceus (Huangqi) on TNF-α expression in murine viral myocarditis [J]
    1133. Effects of Lactobacillus casei Shirota ingestion on common cold infection and herpes virus antibodies in endurance athletes: a placebo-controlled …
    1134. Effects of pharmacological cyclin-dependent kinase inhibitors on viral transcription and replication
    1135. Effects of Phyllanthus plant extract s on duck hepatitis B virus in vitro and in vivo
    1136. Effects of Phyllathus Amarus on Hepatitis B virus
    1137. Effects of plastic screens on virus infection, yield and qualitative characteristics of small tomatoes
    1138. Effects of propolis FLAVONOIDS on virus infectivity and replication.
    1139. Effects of rutin and quercetin on monooxygenase activities in experimental influenza virus infection
    1140. Effects of Shenqi Fuzheng injection on Fas/FasL protein expression levels in the cardiomyocytes of a mouse model of viral myocarditis
    1141. Effects of silymarin on hepatitis C virus and haem oxygenase‐1 gene expression in human hepatoma cells
    1142. Effects of silymarin supplementation in patients with chronic hepatitis C receiving PEG-IFN+ ribavirin antiviral therapy. A placebo-controlled double blind study
    1143. Effects of Sulfated Glucomannan on the antiviral Activity of Broiler Infected with IBDV
    1144. Effects of the combination of baicalin and ribavirin on influenza A virus infection in vitro and in vivo
    1145. Effects of TheraMax on influenza virus infections in cell culture and in mice
    1146. Effects of Total flavone s from Taraxaci Herba on Ardiomyocyte Apoptosis in Mice with viral Myocarditis [J]
    1147. Effects of total flavonids of astragalus on arrhythmia, endoplasmic reticulum stress in mice with viral myocarditis
    1148. Effects of triterpenoids and FLAVONOIDS isolated from Alnus firma on HIV-1 viral enzymes
    1149. Effects of viral replication on cellular membrane metabolism and function
    1150. Effects of Xinjiaxiangruyin on the TLR7 pathway in influenza virus -infected lungs of mice housed in a hygrothermal environment
    1151. Efficacy of Bidens pilosa extract against herpes simplex virus infection in vitro and in vivo
    1152. Efficacy of Brazilian propolis against herpes simplex virus type 1 infection in mice and their modes of antiherpetic efficacies
    1153. Efficacy of Echinacea purpurea and protexin on systemic and mucosal immune response to Newcastle diseases virus vaccination (VG/GA strain) in commercial turkey …
    1154. Efficacy of extract s and iridoid glucosides from Pentas lanceolata on humoral and cell-mediated immune response of viral vaccine
    1155. Efficacy of Garlic and Onion against virus
    1156. Efficacy of hepatoprotective agents with or without antiviral drugs on liver function and fibrosis in patients with hepatitis B: a meta-analysis
    1157. Efficacy of Houttuynia cordata Thunb. extract s Against Herpes Simplex virus Infection
    1158. Efficacy of Korean traditional medicines against influenza virus infection in mice and their modes of anti-influenza virus action
    1159. Efficacy of orally administered Lobelia chinensis extract s on herpes simplex virus type 1 infection in BALB/c mice
    1160. Egyptian propolis: 2. Chemical composition, antiviral and antimicrobial activities of East Nile Delta propolis
    1161. Eleusine indica Inhibits Early and Late Phases of Herpes Simplex virus Type 1 Replication Cycle and Reduces Progeny Infectivity
    1162. Emerging therapeutic targets in antiviral and anticancer therapy: a role for ribonucleotide reductase
    1163. Emerging Trends in Non-Interferon-Based Genotype-Specific antiviral Agents: Pharmaceutical Perspectives
    1164. Empirical studies on the extract s from compatibility of Flos Lonicerae and Forsythia suspense inhibiting influenza A virus FM1 strain in vitro [J]
    1165. Empirical study in vitro of inhibiting action of membranaceus component A6 on influenza virus [J]
    1166. End points for testing influenza antiviral treatments for patients at high risk of severe and life-threatening disease
    1167. Endonuclease activity inhibition of the NS1 protein of parvovirus B19 as a novel target for antiviral drug development
    1168. Enhancement of in vivo anti-influenza virus activity of 5, 7, 4′-trihydroxy-8-methoxyflavone by drug delivery system using hydroxypropyl cellulose
    1169. Enhancement of the Herpes Simplex virus Thymidine Kinase/Ganciclovir Bystander Effect and Its Antitumor Efficacy In Vivo by Pharmacologic Manipulation of Gap …
    1170. Ent-kaurene Diterpenoids from Sideritis lycia with antiviral and Cytotoxic Activities
    1171. Environmental risk factors for multiple sclerosis. Results from animal and human studies on diet, vitamin D and Epstein-Barr virus
    1172. Enzymatic synthesis of novel phenol acid rutinosides using rutinase and their antiviral activity in vitro
    1173. Epidemiological analysis on viral hepatitis in Hangzhou city Xiacheng county from year 1998 to 2007 [J]
    1174. Epidemiological Investigcation of and Control Strategies for Swine viral Diarrhea [J]
    1175. Epimedium koreanum Nakai displays broad spectrum of antiviral activity in vitro and in vivo by inducing cellular antiviral state
    1176. Epimedium koreanum Nakai water extract exhibits antiviral activity against porcine epidermic diarrhea virus in vitro and in vivo
    1177. EPs® 7630 (Umckaloabo®), an extract from Pelargonium sidoides roots, exerts anti-influenza virus activity in vitro and in vivo
    1178. Epstein-Barr virus (EBV) reactivation and therapeutic inhibitors
    1179. Epstein–Barr virus : diseases linked to infection and transformation
    1180. Ergosterol peroxide suppresses influenza A virus -induced pro-inflammatory response and apoptosis by blocking RIG-I signaling
    1181. Essential oils of aromatic plant s with antifungal, antibacterial, antiviral , and cytotoxic properties–an overview
    1182. Establishment and analysis of the reference sequence of CoxA16 virus prevailing in mainland China
    1183. Establishment of a stable cell line coexpressing dengue virus -2 and green fluorescent protein for screening of antiviral compounds
    1184. Establishment of chicken embryo fibroblast model for ginsenoside with molecular modification against Marek’s disease virus in vitro
    1185. Establishment of Simple Cell-based Screening Assay and the Identification of Potent antiviral Activity of a plant extract against HSV-1
    1186. Ethanol extract and chromatographic fractions of Tamarindus indica stem bark inhibits Newcastle disease virus replication
    1187. Ethanol extract from Ampelopsis sinica root exerts anti-hepatitis B virus activity via inhibition of p53 pathway in vitro
    1188. Ethanol extract s of Cassia grandis and Tabernaemontana cymosa inhibit the in vitro replication of dengue virus serotype 2
    1189. Ethnobotanical survey of some cameroonian plant s used for the treatment of viral disease
    1190. Ethnomedicinal Wisdom: An Approach for antiviral Drug Development
    1191. Ethnomedicines in antiviral Drug Discovery
    1192. Etiology of Chronic Disease: A Discussion on Ep-stein-Barr virus
    1193. Eupafolin and ethyl acetate fraction of Kalanchoe gracilis stem extract show potent antiviral activities against enterovirus 71 and coxsackievirus A16
    1194. Eupatorium fortunei and its components increase antiviral immune responses against RNA virus es
    1195. Evaluating the efficacy of Achillea millefolium and Thymus vulgaris extract s against Newcastle disease virus in Ovo
    1196. Evaluation of active fraction from plant extract s of Alstonia scholaris for its in–vitro and in–vivo antiviral activity
    1197. Evaluation of an intensive intermittent-induction regimen and duration of short-course treatment for human immunodeficiency virus -related pulmonary tuberculosis
    1198. Evaluation of anti-viral activity of Jatropha curcas leaf extract s against potentially drug-resistant HIV isolates
    1199. Evaluation of anti‐infective potential of a tribal folklore Odina wodier Roxb against some selected microbes and herpes simplex virus associated with skin infection
    1200. Evaluation of antibacterial, antifungal, antiviral , and antioxidant potentials of some edible oils and their fatty acid profiles
    1201. EVALUATION OF antiviral ACTIVITIES OF DIFFERENT TYPES OF PROPOLIS extract S
    1202. Evaluation of antiviral activities of Houttuynia cordata Thunb. extract , quercetin, quercetrin and cinanserin on murine coronavirus and dengue virus infection
    1203. Evaluation of antiviral activity of aqueous extract s from Achyrocline satureioides against Western equine encephalitis virus
    1204. Evaluation of antiviral activity of Azadirachta indica (Neem) bark extract against Newcastle disease virus
    1205. Evaluation of antiviral activity of compounds isolated from Ranunculus sieboldii and Ranunculus sceleratus
    1206. Evaluation of antiviral activity of Ocimum sanctum and Acacia arabica leaves extract s against H9N2 virus using embryonated chicken egg model
    1207. Evaluation of antiviral activity of Oligonol, an extract of Litchi chinensis, against betanodavirus
    1208. Evaluation of antiviral activity of phenolic compounds and derivatives against rabies virus
    1209. Evaluation of antiviral activity of South American plant extract s against herpes simplex virus type 1 and rabies virus
    1210. Evaluation of antiviral and Antimicrobial Activities of Ribes Species Growing in Turkey
    1211. Evaluation of antiviral and Antioxidant Activity of Selected herbal extract s
    1212. Evaluation of antiviral and cytotoxic activities of methanolic extract of S. grandiflora (Fabaceae) flowers
    1213. Evaluation of antiviral and Cytotoxic Activities of Methanolic extract of Thespesia Populnea (Malvaceae) Flowers
    1214. Evaluation of antiviral effect and toxicity of total FLAVONOIDS extract ed from Robinia pseudoacacia cv. idaho
    1215. Evaluation of antiviral effect of Epigallocatechin gallate, Epigallocatechin, Epicatechin gallate and green tea extract against fowl Adenovirus -4
    1216. Evaluation of antiviral Effect of Rutagraveolens extract on Herpes Simplex virus Type 1 in Human Cell Line
    1217. Evaluation of antiviral potential of different Cholistani plant s against infectious bursal disease and infectious bronchitis virus
    1218. Evaluation of antiviral principles for the induction of systemic resistance in blackgram (Vigna mungo) against Urdbean Leaf Crinkle virus
    1219. Evaluation of cytotoxicity and antiviral activity of ivermectin against Newcastle disease virus .
    1220. Evaluation of cytotoxicity, anti-herpes simplex virus type 1 (HSV-1) and antibacterial activities of Ficus vasta and phytoconstituents
    1221. Evaluation of direct antiviral activity of the Deva-5 herb formulation and extract s of five Asian plant s against influenza A virus H3N8
    1222. Evaluation of immune Boosting Properties and Combating of Multiple Respiratory viral Infections by fifteen Euphorbiaceae plant extract s
    1223. Evaluation of in Vitro antiviral Activity of Centaurea Kotschyi var. Decumbens extract s Against Herpes Simplex virus Type 1 (HSV-1)
    1224. Evaluation of in vitro antiviral activity of Vitex Negundo L., Hyptis suaveolens (L) poit., Decalepis hamiltonii Wight & Arn., to Chikungunya virus
    1225. Evaluation of in vitro antiviral activity of Vitex Negundo L., Hyptis suaveolens (L) poit., Decalepis hamiltonii Wight & Arn., to Chikungunya virus
    1226. Evaluation of Jatropha curcas Linn. leaf extract s for its cytotoxicity and potential to inhibit hemagglutinin protein of influenza virus
    1227. Evaluation of natural products as inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase
    1228. Evaluation of phytoconstituents and molecular docking against NS3 protease of hepatitis C virus
    1229. Evaluation of plant extract s: Artemisia afra and Annona muricata for inhibitory activities against Mycobacterium tuberculosis and Human immunodeficiency virus
    1230. EVALUATION OF POTENTIAL antiviral ACTIVITY OF THE HYDROALCOHOLIC extract OF LEMON BALM L. AGAINST HERPES SIMPLEX virus TYPE 1
    1231. Evaluation of protective effect of Erythrina variegata and Spondias pinnata in cadmium intoxicated rats and their antiviral activity against PPR and CSF virus in …
    1232. Evaluation of the activity of Tontelea micrantha extract s against Bacteria, Candida and Mayaro virus .
    1233. Evaluation of the anti-neuraminidase activity of the traditional Chinese medicines and determination of the anti-influenza A virus effects of the neuraminidase inhibitory …
    1234. Evaluation of the antioxidant and antiviral actions of herbal preparations: Rovital and Carciverin V (C1983)
    1235. Evaluation of the antiviral activities of Bacharis dracunculifolia and quercetin on Equid herpesvirus 1 in a murine model
    1236. EVALUATION OF THE antiviral ACTIVITY OF Ballota glandulosissima Hub.-Mor. & Patzak extract S AGAINST RESPIRATORY SYNCYTIAL virus …
    1237. Evaluation of the antiviral activity of kaempferol and its glycosides against human cytomegalovirus
    1238. Evaluation of the antiviral activity of sage leaves (Salvia officinalis) extract against foot-and-mouth disease virus .
    1239. Evaluation of the antiviral effects of aqueous extract s of red and yellow onions (Allium Cepa) against avian influenza virus subtype H9N2
    1240. Evaluation of the antiviral Potential of Halogenated DihydrorugosaFLAVONOIDS and Molecular Modeling with nsP3 Protein of Chikungunya virus (CHIKV)
    1241. Evaluation of the role of the antioxidant silymarin in modulating the in vivo genotoxicity of the antiviral drug ribavirin in mice
    1242. Evaluation of the Sensitivity of Measles virus and Herpes Simplex virus -1 to Three Locally Available Herbs in Nigeria
    1243. Evaluation of the use of different solvents to extract the four main components of Yinqiaosan and their in vitro inhibitory effects on influenza-A virus
    1244. Evaluation of the virucidal efficacy of commercial antiviral drugs against Lasota virus a surrogate for enveloped virus es
    1245. Evaluation on anti-hepatitis viral activity of Vitis vinifer L
    1246. Evans blue inhibits HBV replication through a dual antiviral mechanism by targeting virus binding and capsid assembly
    1247. Evidence for clinical use of honey in wound healing as an anti-bacterial, anti-inflammatory anti-oxidant and anti-viral agent: A review
    1248. Evodia rutaecarpa and three major alkaloids abrogate influenza A virus (H1N1)-induced chemokines production and cell migration
    1249. Evolution of new variants/mutants of JE virus , its effect on neurovirulence, antigenicity, host immune responses and disease transmission in endemic areas
    1250. Examining dioxin-mediated alterations in pulmonary immune cell function during influenza virus infection: effects on cytolytic activity and interferon gamma
    1251. Experimental studies on inhibitory effects of total FLAVONOIDS in Scorzonera austriaca Wild on hepatitis B virus in vitro
    1252. Experimental study of the effect of water extract s from Helicteres angustifolia on anti-hepatitis B virus and protecting hepatocyte activity in vitro [J]
    1253. Experimental study of water extract from Helicteres Angustifolia on duck Hepatitis B virus in vivo
    1254. Experimental Study on Anti-Duck Hepatitis B viral Effect of Phyllanthus urinaria of Different Areas and Combined Therapy with Other Drugs [J]
    1255. Experimental Study on antiviral Effect of Protoporphyrin Disodium on Duck Hepatitis B virus [J]
    1256. Experimental Study on Effect of Anti-Influenza virus of Shengjiang Powder [J]
    1257. Experimental study on effect of chlorophyll-carotene ointment from pine needles against influenza A virus in vitro [J]
    1258. Experimental Study on Effect of Different Radix extract s on Anti-Influenza virus A
    1259. Experimental study on effect of maxing shigan decoction on anti-influenza virus A in vitro
    1260. Experimental study on guanzhong anti-influenza a virus FM1 strain
    1261. Experimental Study on Influence of Embryo-Bud Nourishing Capsule on serum IL-2 and TNF-α in Mice with Influenza virus Infection [J]
    1262. Experimental Study on Kegan Compound Inhibit Influenza virus Infection
    1263. Experimental study on the action of Yinqiaosan against Influenza virus A_1.[J]
    1264. Exploration of (hetero) aryl Derived Thienylchalcones for antiviral and Anticancer Activities
    1265. Exploration of the mechanisms of Ge Gen Decoction against influenza A virus infection
    1266. Exploring FLAVONOIDS for the Inhibition of Hepatitis C virus by Targeting NS3 Protease
    1267. Expression and function of chemokines during viral infections: from molecular mechanisms to in vivo function
    1268. Expression and identification of Nucleoprotein (NP) of Influenza A virus and Prediction B cell epitopes at NP
    1269. Expressional screening of interferon‐stimulated genes for antiviral activity against hepatitis C virus replication
    1270. Extent of human immunodeficiency virus type 1 drug resistance as a predictor of virological failure after genotype-guided treatment switch
    1271. extract from Aphloia theiformis, an edible indigenous plant from Reunion Island, impairs Zika virus attachment to the host cell surface
    1272. extract of Scutellaria baicalensis inhibits dengue virus replication
    1273. extract ion of Chlorogenic Acid from Chinese herbal Medicine and its antiviral Effect on Porcine Parvovirus in Vitro
    1274. extract ion of Total Lignans from Radix Isatidis and Its Ant-RSV virus Effect
    1275. extract ion of total lignans from radix isatidis and its antiviral activity
    1276. extract ion of Volatile Oil from Houttuynia Cordata and Its Anti-biotic and Anti-virus Activities [J]
    1277. extract s and Constituents of Hypericum Perforatum Inhibit the Binding of Various Ligands to Recombinant Receptors Expressed with the Semliki Forest virus System
    1278. extract s from Acacia catechu suppress HIV-1 replication by inhibiting the activities of the viral protease and Tat
    1279. extract s of Equisetum giganteum L and Copaifera reticulate Ducke show strong antiviral activity against the sexually transmitted pathogen herpes simplex virus type 2
    1280. extract s of Moringa oleifera Lam. showing inhibitory activity against early steps in the infectivity of HIV-1 lentiviral particles in a viral vector-based screening
    1281. Ficus religiosa L. bark extract s inhibit human rhinovirus and respiratory syncytial virus infection in vitro
    1282. Ficus religiosa L. bark extract s inhibit infection by herpes simplex virus type 2 in vitro
    1283. Fight against H1N1 influenza A virus : recent insights towards the development of druggable compounds
    1284. Finding natural Inhibitor for NS3 Protease Enzyme from Dengue virus via Molecular Modeling
    1285. Five years of progress on cyclin-dependent kinases and other cellular proteins as potential targets for antiviral drugs
    1286. flavanone glycosides from Citrus junos and their anti-influenza virus activity
    1287. Flaviviridae virus es and oxidative stress: implications for viral pathogenesis
    1288. Flavivirus Protease: An antiviral Target
    1289. Flavocoxid exerts a potent antiviral effect against hepatitis B virus
    1290. flavone C-glycosides from the leaves of Lophatherum gracile and their in vitro antiviral activity
    1291. flavone enhances dengue virus type-2 (NGC strain) infectivity and replication in Vero cells
    1292. Flavonoid baicalin inhibits HIV-1 infection at the level of viral entry
    1293. Flavonoid from Carica papaya inhibits NS2B-NS3 protease and prevents Dengue 2 viral assembly
    1294. Flavonoid Glycosides From the Bulbs of Lilium speciosum var. gloriosoides and their Potential antiviral Activity Against RSV
    1295. FLAVONOIDS as antiviral agents for Enterovirus A71 (EV-A71)
    1296. FLAVONOIDS as multi-target inhibitors for proteins associated with Ebola virus : In silico discovery using virtual screening and molecular docking studies
    1297. FLAVONOIDS as noncompetitive inhibitors of Dengue virus NS2B-NS3 protease: inhibition kinetics and docking studies
    1298. FLAVONOIDS extract ed from fruit pulp of Cucumis metuliferus have antiviral properties
    1299. FLAVONOIDS from Adina pilulifera and Their in vitro antiviral Activity.
    1300. FLAVONOIDS from Houttuynia cordata attenuate H1N1-induced acute lung injury in mice via inhibition of influenza virus and Toll-like receptor signalling
    1301. FLAVONOIDS from Matteuccia struthiopteris and Their Anti-influenza virus (H1N1) Activity
    1302. FLAVONOIDS from Pterogyne nitens inhibit hepatitis C virus entry
    1303. FLAVONOIDS from the seeds of hovenia acerba and their in vitro antiviral activity
    1304. FLAVONOIDS isolated from Foeniculum vulgare (Fennel) have virostatic efficiency against bluetongue virus
    1305. FLAVONOIDS with antiviral activity isolated from infusion leaves of Persea americana (lauraceae); Flavonoides com atividade antiviral isolados do infuso de folhas de …
    1306. Flavonoids: promising natural compounds against viral infections
    1307. Flavonol monoglycosides isolated from the antiviral fractions of Persea americana (Lauraceae) leaf infusion
    1308. Food products and the ways of protection from viral diseases
    1309. Fostering the antiviral activity of green tea extract for sanitizing purposes through controlled storage conditions
    1310. Four Matrine-Based alkaloids with antiviral Activities against HBV from the Seeds of Sophora alopecuroides
    1311. French maritime pine bark extract inhibits viral replication and prevents development of viral myocarditis
    1312. Fructans as immunomodulatory and antiviral Agents: The Case of Echinacea
    1313. Functional analysis of soybean genes involved in flavonoid biosynthesis by virus ‐induced gene silencing
    1314. Functional evaluation of synthetic FLAVONOIDS and chalcones for potential antiviral and anticancer properties
    1315. Functional restoration of exhausted CD4+ and CD8+ T cells in chronic viral infection by vinegar-processed flos of Daphne genkwa
    1316. Fungal bioactive compounds with antiviral effect
    1317. Further evaluation of Rwandan medicinal plant extract s for their antimicrobial and antiviral activities
    1318. GA-Hecate antiviral properties on HCV whole cycle represent a new antiviral class and open the door for the development of broad spectrum antiviral s
    1319. Gan-Lu-Siao-Du-yin, a prescription of traditional Chinese medicine, inhibited enterovirus 71 replication, translation, and virus -induced cell apoptosis
    1320. Garlic organosulfur compounds reduce inflammation and oxidative stress during dengue virus infection
    1321. Gas chromatography-mass spectroscopy analysis of bioactive Petalostigma extract s: Toxicity, antibacterial and antiviral activities
    1322. Gastrin or Motilin Level in the viral Hepatitis B Patients with Liver-Qi Stagnation and Spleen Deficiency
    1323. GBP1 exerts inhibitory effects on acute viral myocarditis by inhibiting the inflammatory response of macrophages in mice
    1324. Gegen Qinlian Decoction Downregulates the TLR7 Signalling Pathway to Control Influenza A virus Infection
    1325. Gene discovery in Catharanthus roseus using virus induced gene silencing
    1326. Gene expression changes in leaves of Citrus sinensis (L.) Osbeck infected by Citrus tristeza virus
    1327. Gene expression profiles underlying selective T-cell-mediated immunity activity of a Chinese medicine granule on mice infected with influenza virus H1N1
    1328. Gene-Eden-VIR is antiviral : results of a post marketing clinical study
    1329. Generation and characterization of a mutant of influenza A virus selected with the neuraminidase inhibitor BCX-140
    1330. Genetic evidence for genotoxic effect of entecavir, an anti-Hepatitis B virus nucleotide analog
    1331. Genetic Mutation of Hemagglutinin Gene of Influenza A virus in Guangzhou [J]
    1332. Genistein as antiviral drug against HIV ion channel
    1333. Genistein Has antiviral Activity against Herpes B virus and Acts Synergistically with antiviral Treatments to Reduce Effective Dose
    1334. Genistein inhibits African swine fever virus replication in vitro by disrupting viral DNA synthesis
    1335. Genistein inhibits the replication of avian leucosis virus subgroup J in DF-1 cells
    1336. Genus Phyllanthus for chronic hepatitis B virus infection: a systematic review
    1337. Ghost probiotics with a combined regimen: a novel therapeutic approach against the Zika virus , an emerging world threat
    1338. Gliotoxin: inhibitor of poliovirus RNA synthesis that blocks the viral RNA polymerase 3Dpol.
    1339. Global gene response to virus infections in grapevine
    1340. Global Scenario of antiviral Dr
    1341. Gossypin as a novel selective dual inhibitor of V-RAF murine sarcoma viral oncogene homolog B1 and cyclin-dependent kinase 4 for melanoma
    1342. Grape seed extract attenuates hepatitis C virus replication and virus -induced inflammation
    1343. Grapevine virus diseases: economic impact and current advances in viral prospection and management
    1344. Green synthesis of silver nanoparticles from medicinal plant s and evaluation of their antiviral potential against chikungunya virus
    1345. Green tea catechins adsorbed on the murine pharyngeal mucosa reduce influenza A virus infection
    1346. Green tea phenolic epicatechins inhibit hepatitis C virus replication via cycloxygenase-2 and attenuate virus -induced inflammation
    1347. Green tea: a potential alternative anti-infectious agent catechins and viral infections
    1348. Green-synthesized silver nanoparticles as a novel control tool against dengue virus (DEN-2) and its primary vector Aedes aegypti
    1349. Guava flavonoid glycosides prevent influenza A virus infection via rescue of P53 activity
    1350. Guideline on Clinical Evaluation of antiviral Agents for Treatment of Chronic Hepatitis C
    1351. Haematological Parameters of Broilers Fed Moringa oleifera Leaf Supplemented Feed Following Challenge with a Very Virulent Infectious Bursal Disease virus
    1352. Haemogram and serum enzymes activities of Newcastle disease virus challenged broiler chickens following supplemental treatment with aloe vera extract
    1353. Halogenated Chrysins inhibit Dengue and Zika virus infectivity
    1354. heme oxygenase-1 agonist CoPP suppresses influenza virus replication through IRF3-mediated generation of IFN-α/β
    1355. Hemophagocytic lymphohistiocytosis secondary to human immunodeficiency virus -associated histoplasmosis
    1356. HEPATITIS B virus
    1357. Hepatitis C virus and natural compounds: a new antiviral approach?
    1358. Hepatitis C virus and oxidative stress: a dangerous liaison
    1359. Hepatitis C virus complete life cycle screen for identification of small molecules with pro-or antiviral activity
    1360. Hepatitis C virus core protein activates Wnt/β-catenin signaling through multiple regulation of upstream molecules in the SMMC-7721 cell line
    1361. Hepatitis C virus entry and cell-cell transmission: implication for viral life cycle and antiviral treatment
    1362. Hepatitis C virus experimental model systems and antiviral drug research
    1363. Hepatitis C virus NS5A and core proteins induce oxidative stress-mediated calcium signalling alterations in hepatocytes
    1364. Hepatitis C virus , oxidative stress and steatosis: current status and perspectives
    1365. Hepatoprotective and a Potential antiviral Effect of Biphenyl Dimethyl Dicarboxylate/amantadine for an Acute V iral Hepatitis Induced by MHV-2in ICR Mice
    1366. Hepatoprotective and antiviral efficacy of Acacia mellifera leaves fractions against hepatitis B virus
    1367. Hepatoprotective and antiviral functions of silymarin components in hepatitis C virus infection
    1368. Hepatoprotective, anticancer & antiviral effects of Bhui Amla in unani medicine: an overview
    1369. herbal extract s and compounds active against herpes simplex virus
    1370. herbal extract s as antiviral agents
    1371. herbal gel formulation developed for anti-human immunodeficiency virus (HIV)-1 activity also inhibits in vitro HSV-2 infection
    1372. herbal lead as ideal bioactive compounds against probable drug targets of Ebola virus in comparison with known chemical analogue: A computational drug discovery …
    1373. herbal medicines with antiviral activity against the influenza virus , a systematic review
    1374. herbal plant s and plant preparations as remedial approach for viral diseases
    1375. herbal product use by persons enrolled in the hepatitis C antiviral Long‐Term Treatment Against Cirrhosis (HALT‐C) Trial
    1376. Herbs for Emerging viral Infectious Diseases
    1377. Herbs for viral Respiratory Infections
    1378. Herpes simplex virus type 1 and Alzheimer’s disease: link and potential impact on treatment
    1379. Herpes simplex virus type 1 propagation in HeLa cells interrupted by Nelumbo nucifera
    1380. Herpes simplex virus : Drug resistance and new treatment options using natural products
    1381. Herpes simplex virus es in antiviral drug discovery
    1382. Herpes virus inhibitory substances from Hypericum connatum Lam., a plant used in southern Brazil to treat oral lesions
    1383. Hesperetin protects crayfish Procambarus clarkii against white spot syndrome virus infection
    1384. High Amplification of the antiviral Activity of Curcumin through Transformation into Carbon Quantum Dots
    1385. High correlation between lipid peroxide radical and tumor‐promoter effect: suppression of tumor promotion in the Epstein‐Barr virus /B‐lymphocyte system and …
    1386. High Frequency Shoots Regeneration for Mass Multiplication of Phyllanthus fraternus Webster—An Important antiviral and Hepatoprotective plant
    1387. High molecular weight constituents of cranberry interfere with influenza virus neuraminidase activity in vitro
    1388. High-content assay to identify inhibitors of dengue virus infection
    1389. High-Throughput Screening for Anti–Influenza A virus Drugs and Study of the Mechanism of Procyanidin on Influenza A virus –Induced Autophagy
    1390. Highlights in antiviral drug research: antiviral s at the horizon
    1391. Highly efficient inhibition of spring viraemia of carp virus replication in vitro mediated by bavachin, a major constituent of psoralea corlifonia Lynn
    1392. Highly Pathogenic Avian Influenza A virus : Pathogenesis, Vaccine and antiviral
    1393. Hirsutine, an indole alkaloid of Uncaria rhynchophylla, inhibits late step in dengue virus lifecycle
    1394. HomoisoFLAVONOIDS from Caesalpinia sappan displaying viral neuraminidases inhibition
    1395. Homonojirimycin, an alkaloid from dayflower inhibits the growth of influenza A virus in vitro
    1396. Honey as an antiviral agent against respiratory syncytial virus
    1397. Honeybee (Apis mellifera) venom reinforces viral clearance during the early stage of infection with porcine reproductive and respiratory syndrome virus through the up …
    1398. Honokiol, a lignan biphenol derived from the magnolia tree, inhibits dengue virus type 2 infection
    1399. Houttuynia cordata polysaccharides ameliorate pneumonia severity and intestinal injury in mice with influenza virus infection
    1400. Houttuynia cordata targets the beginning stage of herpes simplex virus infection
    1401. Houttuynoids A–E, Anti-Herpes Simplex virus Active FLAVONOIDS with Novel Skeletons from Houttuynia cordata
    1402. How effective is the Human Papilloma virus Vaccine?
    1403. How to manage recurrent orofacial herpes simplex virus -1 lesions
    1404. HPLC analysis and antimicrobial, antimycobacterial and antiviral activities of Tabernaemontana catharinensis A. DC
    1405. HPLC Quantification of Vitexine-2″-O-rhamnoside and Hyperoside in Three Crataegus Species and Their Antimicrobial and antiviral Activities
    1406. HPLC-DAD-MS Analysis and antiviral Activity of Different extract s and Isolated Constituents from Bituminaria bituminosa
    1407. Human cytomegalovirus -inhibitory flavonoids: studies on antiviral activity and mechanism of action
    1408. Human immunodeficiency virus type 1 inhibitory activity of Mentha longifolia
    1409. Hypericum in infection: Identification of anti-viral and anti-inflammatory constituents
    1410. Hypericum perforatum inhibits the binding of μ-and κ-opioid receptor expressed with the Semliki Forest virus system
    1411. Iatrogenic transmission of hepatitis C virus (HCV) by an anesthesiologist: comparative molecular analysis of the HCV-E1 and HCV-E2 hypervariable regions
    1412. Icariin inhibits the apoptosis of cemx174 triggered by simian immuno deficiency virus infection in vitro
    1413. Identification and characterization of novel alleles required for antiviral RNA interference in Caenorhabditis elegans
    1414. Identification and characterization of two conserved G-quadruplex forming motifs in the Nipah virus genome and their interaction with G-quadruplex specific ligands
    1415. Identification and evaluation of anti hepatitis C virus phytochemicals from Eclipta alba
    1416. Identification and Mechanism Investigation of Anti-Influenza virus Agents from Chinese Prescriptions and Herbs
    1417. Identification and synthesis of quinolizidines with anti-influenza A virus activity
    1418. Identification of 2-(4-(phenylsulfonyl) piperazine-1-yl) pyrimidine analogues as Novel Inhibitors of Chikungunya virus
    1419. Identification of a C2-symmetric diol based human immunodeficiency virus protease inhibitor targeting Zika virus NS2B-NS3 protease
    1420. Identification of a flavonoid isolated from plum (Prunus domestica) as a potent inhibitor of Hepatitis C virus entry
    1421. Identification of a partial mRNA containing UL31 viral protein domain from Celosia cristata expressed sequences
    1422. Identification of antiviral activity of Toddalia asiatica against influenza type A virus
    1423. Identification of Bioactive Compound from Microalga BTM 11 as Hepatitis C virus RNA Helicase Inhibitor
    1424. Identification of bioflavonoid as fusion inhibitor of dengue virus using molecular docking approach
    1425. Identification of differentially expressed genes in response to infection of a mild Citrus tristeza virus isolate in Citrus aurantifolia by suppression subtractive …
    1426. Identification of ellagic acid from plant Rhodiola rosea L. as an anti-Ebola virus entry inhibitor
    1427. Identification of hepatitis C virus inhibitors targeting different aspects of infection using a cell-based assay
    1428. Identification of light-independent inhibition of human immunodeficiency virus -1 infection through bioguided fractionation of Hypericum perforatum
    1429. Identification of Myricetin as an Ebola virus VP35–Double-Stranded RNA Interaction Inhibitor through a Novel Fluorescence-Based Assay
    1430. Identification of POLYPHENOLS from antiviral Chamaecrista nictitans extract using high-resolution LC–ESI–MS/MS
    1431. Identification of potential binding pocket on viral oncoprotein HPV16 E6: a promising anti-cancer target for small molecule drug discovery
    1432. Identification of structural requirements and prediction of inhibitory activity of natural FLAVONOIDS against Zika virus through molecular docking and Monte Carlo based …
    1433. Identifying novel antiviral targets against enterovirus 71: where are we?
    1434. immune and cytokine /chemokine responses of PBMCs in rotavirus ‐infected rhesus infants and their significance in viral pathogenesis
    1435. immune signaling in arabidopsis thaliana upon perception of bacterial and viral molecular patterns with a special emphasis on roots
    1436. Immunogenic properties of solubilized tumour antigen from an RNA virus -transformed neoplasm
    1437. Immunomodulating and antiviral activities of Uncaria tomentosa on human monocytes infected with Dengue virus -2
    1438. immunomodulatory and antioxidant effects of purple sweet potato extract in LP-BM5 murine leukemia virus -induced murine acquired immune deficiency syndrome
    1439. immunomodulatory and antiviral activity of almond skins
    1440. immunomodulatory effect of the Bushen Jianpi recipe on HBeAg-positive hepatitis B virus carriers [J]
    1441. immunomodulatory effects of Shengjiang San on the mice infected with influenza virus FM
    1442. immunomodulatory properties of quercetin-3-O-α-L-rhamnopyranoside from Rapanea melanophloeos against influenza a virus
    1443. Immunoprophylaxis of Type B viral Hepatitis [J]
    1444. Impact of gut colonization with butyrate-producing microbiota on respiratory viral infection following allo-HCT
    1445. Impact of oral silymarin on virus ‐and non‐virus ‐specific T‐cell responses in chronic hepatitis C infection
    1446. Impact of the Revised Guidelines for Respiratory Syncytial virus (RSV) Prophylaxis: Morbidity Persists After Two Seasons!
    1447. In search for effective and definitive treatment of herpes simplex virus type 1 (HSV-1) infections
    1448. In Silico Identification of natural Lead Molecules from the Genus of Phyllanthus Against Hepatitis B virus Reverse Transcriptase
    1449. In silico investigation of hepatitis c virus : a novel perspective into targeted viral inhibition of NS3 helicase, NS 3/4a protease and NS5b RNA dependent RNA …
    1450. In silico prediction of phosphorylation of NS3 as an essential mechanism for Dengue virus replication and the antiviral activity of Quercetin
    1451. In silico screening of chalcones against Epstein-Barr virus nuclear antigen 1 protein
    1452. In Silico Studies against viral Sexually Transmitted Diseases
    1453. IN SILICO STUDIES ON SOME DENGUE viral PROTEINS WITH SELECTED ALLIUM CEPA OIL CONSTITUENTS FROM ROMANIAN SOURCE
    1454. In silico study on anti-Chikungunya virus activity of hesperetin
    1455. In silico study on baicalein and baicalin as inhibitors of dengue virus replication
    1456. In silico virtual screening approaches for anti-viral drug discovery
    1457. In vitro activity of extract s of Persea americana leaves on acyclovir-resistant and phosphonoacetic resistant Herpes simplex virus
    1458. In Vitro analysis of the anti-influenza virus activity of Peperomia sui and Ixeris chinensis
    1459. In Vitro Analysis of the Anti-influenza virus Activity of Pomegranate Products and Fulvic Acid.
    1460. IN VITRO AND EX VIVO EVALUATION OF THE VIRUCIDAL AND antiviral CAPACITIES OF A BIOFLAVONOID AGAINST EQUINE HERPES virus TYPE
    1461. il6 Folg”>In vitro and in silico study to evaluate the effectiveness of quercitrin as antiviral drug to dengue virus
    1462. In vitro and in vivo anti-hepatitis B virus activities of a plant extract from Geranium carolinianum L
    1463. In vitro and in vivo anti-influenza virus activities of FLAVONOIDS and related compounds as components of Brazilian propolis (AF-08)
    1464. In vitro and in vivo effects of Peganum harmala L. seeds extract against influenza A virus
    1465. In vitro and in vivo inhibitory effects of disodium cromoglycate on influenza virus infection
    1466. In vitro and in vivo mechanism of immunomodulatory and antiviral activity of edible Bird’s Nest (EBN) against influenza a virus (IAV) infection
    1467. In vitro anti Coxsackie B_3 virus effect of Luteolin
    1468. In vitro Anti-Herpes simplex Type-1 virus Evaluation of extract s from Kenya Grown Pyrethrum (Chrysanthemum cinerariaefolium)
    1469. In vitro anti-influenza viral activities of stilbenoids from the lianas of Gnetum pendulum
    1470. In vitro anti-influenza virus activities of a new lignan glycoside from the latex of Calotropis gigantea
    1471. In vitro anti-influenza virus activity of 10 traditional Chinese medicines
    1472. In vitro anti-influenza virus activity of a cardiotonic glycoside from Adenium obesum (Forssk.)
    1473. In vitro anti-influenza virus activity of a plant preparation from Geranium sanguineum L.
    1474. In vitro anti-influenza virus and anti-inflammatory activities of theaflavin derivatives
    1475. In vitro anti-influenza virus effect of total flavonoid from Trollius ledebouri Reichb
    1476. In vitro anti-reovirus activity of kuraridin isolated from Sophora flavescens against viral replication and hemagglutination
    1477. In vitro anti-viral activity of psoraleae semen water extract against influenza A virus es
    1478. In vitro Anti‐Herpes Simplex virus Activity of 1,2,4,6‐Tetra‐O‐galloyl‐β‐d‐glucose from Phyllanthus emblica L. (Euphorbiaceae)
    1479. In vitro antibacterial and antiviral activity of Rumex gmelini
    1480. In vitro antibacterial, antimutagenic and anti-influenza virus activity of caffeic acid phenethyl esters
    1481. In Vitro Anticandidal, antiviral and Antioxidant Activities of Cucumis melo L. var. cantalupensis Naud extract s
    1482. In vitro antimicrobial and antiviral activities of the essential oil and various extract s of Salvia cedronella Boiss
    1483. In vitro antimicrobial, antioxidant and antiviral activities of the essential oil and various extract s of wild (Daucus virgatus (Poir.) Maire) from Tunisia
    1484. In vitro antioxidant activity of polyphenol extract s with antiviral properties from Geranium sanguineum L
    1485. In vitro Antioxidant, Antimicrobial and Anti-Herpes Simplex virus Type 1 Activity of Phellodendron amurense Rupr. from China
    1486. In Vitro Antioxidant, Antimicrobial, and antiviral Activities of the Essential Oil and Various extract s from herbal Parts and Callus Cultures of Origanum acutidens
    1487. In vitro antiviral Activities of Aframomum melegueta leaf extract s on Newcastle Disease virus (NDV), Fowl Pox virus (FPV) and Infectious Bursal Disease virus …
    1488. In vitro antiviral Activities of Bryophyllum pinnatum (Odaa opuo) and Viscum album (Awuruse)
    1489. In vitro antiviral activities of Caesalpinia pulcherrima and its related flavonoids
    1490. In vitro antiviral activities of extract s derived from Daucus maritimus seeds
    1491. In vitro antiviral activity against rotavirus and astrovirus infection exerted by substances obtained from Achyrocline bogotensis (Kunth) DC.(Compositae)
    1492. In vitro antiviral activity from Acanthospermum australe on herpesvirus and poliovirus
    1493. In Vitro antiviral Activity of a Series of Wild Berry Fruit extract s against Representatives of Picorna-, Orthomyxo- and Paramyxoviridae
    1494. In Vitro antiviral Activity of Black Tea POLYPHENOLS on Sindbis virus in Vero Cells
    1495. In vitro antiviral activity of Brazilian plant s (Maytenus ilicifolia and Aniba rosaeodora) against bovine herpesvirus type 5 and avian metapneumovirus
    1496. In vitro antiviral activity of chestnut and quebracho woods extract s against avian reovirus and metapneumovirus
    1497. In vitro antiviral activity of clove and ginger aqueous extract s against feline calicivirus , a surrogate for human norovirus
    1498. In vitro antiviral activity of commercial products of herbal extract s against highly pathogenic avian influenza (H5N1) virus .
    1499. In vitro antiviral activity of Eugenia jambolana plant extract on buffalopox virus : Conventional and QPCR methods
    1500. In vitro antiviral activity of fifteen plant extract s against avian infectious bronchitis virus
    1501. In vitro antiviral activity of fisetin, rutin and naringenin against dengue virus type-2
    1502. In Vitro antiviral Activity of Heterophyllaea pustulata extract s
    1503. In vitro antiviral activity of Orthosiphon stamineus extract against dengue virus type 2
    1504. In vitro antiviral activity of Phyllanthus orbicularis extract s against herpes simplex virus type 1
    1505. In vitro antiviral activity of plant extract s against equine herpes virus -1
    1506. In vitro antiviral activity of plant extract s against Infectious Bursal Disease virus
    1507. In vitro antiviral activity of plant extract s from Asteraceae medicinal plant s
    1508. In vitro antiviral activity of plant extract s on goatpox virus replication
    1509. IN VITRO antiviral ACTIVITY OF proanthocyanidin A2 AGAINST CANINE DISTEMPER virus
    1510. In vitro antiviral activity of prodelphinidin B-2 3, 3′-di-O-gallate from Myrica rubra
    1511. In vitro antiviral activity of propolis
    1512. In vitro antiviral activity of propolis and Baccharis sp. extract s on animal herpesvirus es
    1513. In vitro antiviral activity of sakuranetin against human rhinovirus 3
    1514. In vitro antiviral activity of seeds from Guettarda angelica against avian virus es
    1515. In vitro antiviral activity of single domain antibody fragments against poliovirus
    1516. In vitro antiviral activity of thirty-six plant s from La Réunion Island
    1517. In vitro antiviral activity of three enantiomeric sesquiterpene lactones from Senecio species against hepatitis B virus
    1518. In vitro antiviral activity of twenty-seven medicinal plant extract s from Southwest Nigeria against three serotypes of echovirus es
    1519. In vitro antiviral and antimicrobial activities of Spirulina platensis extract
    1520. In vitro antiviral and cytotoxic screening of methanolic extract of Cassia auriculata flowers in HeLa, Vero, CRFK and HEL cell lines
    1521. In vitro antiviral effect of flavonoid-rich extract s of Vitex polygama (Verbenaceae) against acyclovir-resistant herpes simplex virus type 1
    1522. In vitro antiviral Effects and 3D QSAR Study of Resveratrol Derivatives as Potent Inhibitors of Influenza H1N1 Neuraminidase
    1523. In vitro antiviral effects of Peganum harmala seed extract and its total alkaloids against Influenza virus
    1524. In vitro antiviral potential of Ocimum basilicum and Olea europaea leaves extract against Newcastle Disease virus of poultry
    1525. In vitro antiviral , anti-inflammatory, and antioxidant activities of the ethanol extract of Mentha piperita L.
    1526. In vitro assessment of the antiviral potential of trans-cinnamic acid, quercetin and morin against equid herpesvirus 1
    1527. In vitro bacterial and viral response in head kidney leukocytes of Atlantic salmon (Salmo salar) fed dietary insects meal.
    1528. In vitro Broad antiviral Function against HBV, HSV, H3N2 Replication by Baicalin and Oroxylin A-7-O-Β-D-Glucoside
    1529. In vitro characterization of a miR-122-sensitive double-helical switch element in the 5′ region of hepatitis C virus RNA
    1530. In vitro cytotoxic, antioxidant and antiviral effects of Pterocaulon alopecuroides and Bidens segetum extract s
    1531. In Vitro Cytotoxic, antiviral and immunomodulatory Effects of plant ago major and plant ago asiatica
    1532. In vitro cytotoxicity and anti-herpes simplex virus type 1 activity of hydroethanolic extract , fractions, and isolated compounds from stem bark of Schinus …
    1533. In vitro Effect of Bioactive Compounds on Influenza virus Specific B‐ and T‐Cell Responses
    1534. In Vitro Effects of Pomegranate Juice and Pomegranate POLYPHENOLS on Foodborne viral Surrogates
    1535. In vitro evaluation of antiprotozoal and antiviral activities of extract s from Argentinean Mikania species
    1536. In vitro evaluation of antiviral activity of leaf extract s of Azadirachta indica, Moringa oleifera, and Morus alba against the foot and mouth disease virus on BHK-21 …
    1537. In vitro evaluation of antiviral effect of bauer-7-en-3b-yl acetate, the major constituent of a sample of Brazilian propolis, against Alphaherpesvirus es
    1538. In vitro evaluation of novel antiviral activities of 60 medicinal plant s extract s against hepatitis B virus
    1539. In vitro evaluation of novel inhibitors against the NS2B-NS3 protease of dengue fever virus type 4
    1540. In vitro evaluation of the antiviral activity of an extract of date palm (Phoenix dactylifera L.) pits on a Pseudomonas phage
    1541. In vitro evaluation of the antiviral activity of extract s from the lichen parmelia perlata (L) Ach. Against three RNA virus es
    1542. In vitro evaluation of the antiviral activity of extract s of Gynostemma pentaphyllum against poliomyelitis virus .
    1543. In Vitro Evaluation Of The antiviral Potential Of Guettarda Angelica Against Animal Herpesvirus es [avaliação In Vitro Do Potencial antiviral De Guettarda Angelica …
    1544. IN Vitro Experimental Evaluation of antiviral and Anticancer Potentials of Both Orange Albedo and Grape Seed extract s
    1545. In vitro inhibition of canine distemper virus by FLAVONOIDS and phenolic acids: implications of structural differences for antiviral design
    1546. In vitro inhibition of Hepatitis C virus protease and antioxidant by flavonoid glycosides from the Saudi costal plant Sarcocornia fruticosa
    1547. In Vitro Inhibition of Human Influenza A virus Infection by Fruit-Juice Concentrate of Japanese Plum (Prunus mume SIEB. et ZUCC)
    1548. In vitro inhibition of neuraminidase activity of influenza virus (H5N2) by methanolic soluble fraction of Ganoderma lucidum extract
    1549. In Vitro inhibitory activity of Alpinia katsumadai extract s against influenza virus infection and hemagglutination
    1550. In vitro inhibitory activity of Justicia adhatoda extract s against influenza virus infection and hemagglutination
    1551. In vitro inhibitory effects of the herbal -marine compound HESA-A against replication of human immunodeficiency virus -1
    1552. In vitro investigation on the effect of a plant preparation with antiviral activity on the functions of mice phagocyte cells
    1553. In vitro permeation and biological activity of punicalagin and zinc (II) across skin and mucous membranes prone to Herpes simplex virus infection
    1554. In vitro Primary Evaluation of antiviral Activity of Crude extract of Quercus ilex L. Against Amantadine Resistant Orthomyxo virus
    1555. In vitro screening for antiviral activity of Turkish plant s revealing methanolic extract of Rindera lanata var. lanata active against human rotavirus
    1556. In vitro screening for compounds derived from traditional chinese medicines with antiviral activities against porcine reproductive and respiratory syndrome virus
    1557. In vitro studies of core peptide‐bearing immunopotentiating reconstituted influenza virosomes as a non‐live prototype vaccine against hepatitis C virus
    1558. In Vitro Studies of Some Medicinal plant s extract s for antiviral Activity against Rotavirus
    1559. In vitro study of antiviral activity of plant crude-extract s against the foot and mouth disease virus
    1560. In vitro study of eight Indonesian plant s extract s as anti Dengue virus
    1561. In Vitro study of Garcinia celebica L. Stem Barks against Hepatitis C virus and Hepatocellular Carcinoma
    1562. In vitro study on anti-hepatitis C virus activity of Spatholobus suberectus Dunn
    1563. In Vitro Synergistic enhancement of Newcastle Disease virus to Methotrexate cytotoxicity against tumor cells
    1564. In vitro testing of antiviral , antibacterial, antifungal effects and cytotoxicity of selected Turkish Phlomis species
    1565. In vitro virucidal activity of hexane fraction of Marrubium vulgare against type 1 herpes simplex virus
    1566. In vitro’antiviral activity of neem (Azadirachta indica. A. Juss) leaf extract against group B coxsackievirus es.
    1567. In Vivo and in Vitro antiviral Activities of Calycosin-7-O-β-D-glucopyranoside against Coxsackie virus B3
    1568. In vivo and in vitro antiviral